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ABSTRACT OF DISSERTATION 
 
 
THE EFFECT OF β-HYDROXY-β-METHYLBUTYRATE (HMB) SUPPLEMENTATION 
ON NEUROMUSCULAR PERFORMANCE FOLLOWING FATIGUING EXERCISE IN 
HEALTHY SUBJECTS 
 
 
Supporters of a nutritional supplement, β-Hydroxy-β-Methylbutyrate (HMB) 
supplementation, claim that it will increase the muscular strength gains and lean muscle 
mass gains seen during a resistance training program.  It has been suggested that HMB 
supplementation does this by preventing muscle damage or by regenerating damaged 
muscle cell membranes.  However, no research has evaluated the effect of HMB 
supplementation on low frequency fatigue. Therefore, the purpose of this study was to 
determine if three weeks of HMB supplementation could attenuate the effects of low 
frequency fatigue caused by eccentric muscle contractions of the tibialis anterior muscle.  
A total of 33 healthy recreationally active subjects (18 males, 15 females; 23.2 ± 4.3 yr) 
were recruited for this study.  All subjects preformed 4 sets of 25 eccentric contractions 
of the tibialis anterior muscle through a range of motion of 30 degrees.  Recovery 
measures were taken for 20 minutes after the fatigue protocol and at 48 and 96 hours of 
recovery.  The recovery measures included:  Maximum voluntary contraction peak 
torque, 10 Hz peak torque, 50 Hz peak torque, 10/50 Hz peak torque ratio, and EMG 
measurements.  Each subject served as their own control and limbs were randomly 
assigned to pre-supplement or post-supplement limbs.  Following the pre-supplement 
fatigue protocol and recovery measures each subject completed three weeks of 3g/day 
HMB supplementation.  After the supplementation period the post-supplement fatigue 
protocol was completed and recovery measures were taken.  The 10 Hz peak torque 
and the 10/50 Hz torque ratio in the pre-supplement limb was still significantly reduced at 
the 96-hour recovery measurement time, indicating that it was still showing low 
frequency muscle fatigue at this time.  Furthermore, the post-supplement limb, 
recovered from the fatigue protocol faster, and did not show any signs of low frequency 
muscle fatigue at the 48-hour recovery measurement time.  In addition the pre-
supplement limb had significant maximum voluntary contraction torque deficit at the 48-
hour recovery measurement time and the post-supplement limb showed no significant 
deficits.  The main findings of this study were that three weeks of HMB supplementation 
attenuated low frequency fatigue and maximum voluntary contraction torque reduction 
after an eccentric fatigue protocol.  
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Chapter 1:  Introduction 
Background 
When the human body participates in any strenuous physical activity there will be a 
decline in muscular performance during that activity and this decline is commonly called 
fatigue (2).  Muscle fatigue can commonly be found in patients in hospitals, elderly 
people, and even middle aged people performing their activities of daily living (2).  This 
type of fatigue is characterized by a loss of muscle strength that results from a decline in 
both muscular force and velocity of contraction.  In addition fatigue is reversible by rest, 
and can be measured by a reduction in force, a change in electromyographic activity or 
an exhaustion of contractile function (11, 14). 
Low frequency fatigue (LFF) is muscular fatigue that occurs at low frequencies of 
stimulation activation (34).  Characteristics of LFF is the reduction in muscle force is 
decreased at low stimulation frequencies, recovery of force is slow, taking hours or days, 
and the effects remain in the absence of gross metabolic or electrical disturbance of the 
muscle (2, 3, 25, 35).  This form of fatigue can be seen after any form of intense 
exercise and is a large contributor to the feeling of weakness in muscles after exercise 
(25, 84). 
The primary implication of LFF is the reduction of muscle force at low frequency 
stimulation and is typically greater than 50% of rested values (25).  Motor unit discharge 
rates during voluntary skeletal muscle activation rarely exceed 30 Hz, so any voluntary 
muscle contraction would be greatly affected by LFF (25).  This would include any 
strenuous activity, walking, stair climbing, and all other activities of daily living (25).   
It has been shown that one of the causes of LFF is the reduced amount of calcium 
(Ca2+) released from the sarcoplasmic reticulum (24).  This reduces the amount of Ca2+ 
that can bind to troponin, reduces the amount of active muscle fibers, and therefore 
reduces the amount of force that the whole muscle can produce (25).  A decrease in 
Ca2+ release affects muscle tension at low frequencies of stimulation to a much greater 
degree than muscle tension at high frequencies (25, 84).  It seems likely that there is 
some degree of structural damage to one or more of the proteins or structures involved 
in excitation contraction coupling and the long time course of LFF represents repair or 
resynthesis of these proteins or structures (25, 84).  In support of this muscle damage 
explanation it has been shown that LFF is a prominent characteristic following eccentric 
exercises and may be seen during the repair process if the muscle fiber was damaged 
during this type of contraction (25). 
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Eccentric muscle contractions produce more muscle damage than concentric or 
static contractions (2, 6, 61).  These types of contractions are part of everyday normal 
activities such as, walking downstairs or lowering a heavy weight and the greater muscle 
damage that is caused is not related to metabolic fatigue but, it is due to a mechanical 
insult (6).  In overstretched sarcomeres the sarcoplasmic reticulum could be damaged or 
its connection with the transverse tubules might be altered (2) .  The evidance for this is 
the LFF that is seen after eccentric muscle contractions (6).  This LFF has been found to 
be caused by excitation contraction uncoupling and in particular a reduced amount of 
Ca2+ release from the sarcoplasmic reticulum (2, 6, 61, 83). 
A nutritional supplement that has gained attention recently is β-Hydroxy-β-
Methylbutyrate (HMB) and it claims to improve recovery following muscle damage.  HMB 
has been associated with increased isometric, isokinetic, and dynamic strength and has 
been generalized across young, elderly, untrained, trained and clinically cachexic 
conditions (88).  HMB is a metabolite of the essential branch chain amino acid leucine 
and is thought to act as an anticatabolic agent, minimizing protein breakdown and 
damage to cells which may occur with intense exercise (72, 79, 92).  It has been 
suggested that HMB supplementation increases muscular strength and lean muscle 
mass gains, seen during a resistance training program, by preventing muscle damage or 
by regenerating damaged muscle cell membranes (26, 43, 46, 53, 66, 88).   
 
Statement of the Problem 
 LFF can be seen after any form of activity and is a large contributor to the feeling 
of weakness in muscles after exercise and force reduction is typically greater than 50% 
of rested values (25, 84).  In addition, recovery of force is slow, and can take hours or 
days (2, 3, 25, 35).  Motor unit discharge rates during voluntary skeletal muscle 
activation rarely exceed 30 Hz, so any voluntary muscle contraction would be greatly 
affected by LFF (25).  This would include any strenuous activity, walking, stair climbing, 
and all other activities of daily living (25).  
HMB supplementation has been associated with increased isometric, isokinetic, and 
dynamic strength and has been generalized across young, elderly, untrained, trained 
and clinically cachexic conditions (88).  HMB supplementation can potentially prevent 
muscle damage or enhance regeneration of damaged muscle cell membranes (26, 43, 
46, 53, 66, 88).  So, HMB supplementation may be effective in reducing LFF caused by 
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muscle damage and to this date a research study has not been found investigating the 
effects of HMB supplementation and the reduction of LFF.  If supplementation with this 
substance can be shown to reduce LFF, caused by fatiguing physical activity, then it 
may provide a quicker recovery for recreational athletes, the general public, and people 
suffering from long term illnesses. 
 
Purpose 
 The purpose of this study was to determine if three weeks of HMB 
supplementation could attenuate the effects of LFF caused by eccentric muscle 
contractions in young healthy adults. 
Hypotheses 
 Hypothesis 1 – There will be two distinct types of fatigue after the eccentric 
fatigue protocol.  This will include a high frequency fatigue, measured by the 50 Hz peak 
torque which will recover faster than the low frequency fatigue, measured by the 10 Hz 
peak torque. 
 Hypothesis 2 – HMB supplementation will reduce the recovery time of low 
frequency fatigue following eccentric exercise.  The 10/50 Hz torque ratio and 10 Hz 
peak torque will recover toward baseline levels faster in the HMB supplemented limb. 
 Hypothesis 3 – HMB supplementation will reduce the recovery time of muscle 
damage caused by eccentric exercise.  The MVC torque will recover toward baseline 
levels faster in the HMB supplemented limb. 
Significance 
The mechanisms of fatigue are complex and multiple mechanisms can influence 
muscle fatigue at the same time.  Based on scientific studies it has been concluded that 
LFF is most likely caused by failure of excitation-contraction coupling or the reduction of 
cross bridge force production (32).  There have been many hypotheses and theories on 
what causes LFF and over the years through different scientific experiments some of 
these hypotheses have been disproven.  But, there has not been any single theory that 
has been proven to explain all of the variables involved in LFF nor have there been any 
procedures or substances that have been shown to entirely block or completely 
eliminate LFF.  The contribution of this research is expected to be the first step in 
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discovering methods or substances that will reduce both LFF and muscle damage.  In 
addition, this research will add to the literature of the severity and time course of LFF.  
This contribution will be significant because it will allow people to participate in their daily 
activities without decreased ability due to LFF and without the discomfort of muscle 
damage. 
 
Delimitations 
This study was delimited to recreationally active males and females between the 
ages of 18-35.  “Recreationally active” was defined as a person who was physically 
active for 60 minutes per day, 3-5 days per week. 
Limitations 
A limitation of this study was that a direct measure of muscle damage was not 
used after the fatigue protocol.  Another limitation of this study was that the subject’s 
physical activity and nutritional intake was not strictly controlled.  The subjects were 
instructed to maintain their same nutritional intake and activity level during the 
supplementation and testing periods.  In addition, a true control group or a placebo 
group was not used for comparison in this study.  
Assumptions 
It was assumed that all subjects gave a maximal effort during all testing 
procedures and that their nutritional intake and physical activity remained constant 
throughout the entire study. 
 
 
 
 
 
 
 
Copyright © Jordon William Macht 2015 
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Chapter II:  Literature Review 
 
Defining Fatigue 
 The term fatigue is very hard to define.  First, we must distinguish between 
subjective fatigue and physiological fatigue.  Subjective fatigue can be defined as 
physical or mental weariness resulting from exertion and it is a feeling that a person 
experiences (12).  So, it is subjective and the amount of fatigue varies depending on the 
person being tested and is very hard to measure accurately and consistently.  
Physiological fatigue on the other hand is not subjective and is easier to measure.  
There are many different definitions of physiological fatigue but, for the purpose of this 
review it will be defined as the “failure to maintain the required or expected force” of a 
particular task (32).  This type of fatigue is characterized by a loss of muscle strength 
that results from a decline in both muscular force and velocity of contraction, and is 
reversible by rest (14).  Muscular fatigue can be measured by a reduction in muscle 
force, a change in electromyographic activity or an exhaustion of contractile function 
(11).   
Another problem with defining physiological fatigue is the question:  when does 
fatigue occur?  It is accepted that fatigue is not the point of task failure or when muscles 
become exhausted (11).  But, it is a decrease in maximal force that the muscles can 
produce and it develops soon after the onset of physical exercise (11). 
 
Central Fatigue Versus Peripheral Fatigue 
 Physiological fatigue can be broken down into two components:  central fatigue 
and peripheral fatigue (32).  Central fatigue is impaired muscular performance that 
arises from the central nervous system (12).  This type of fatigue may be affected during 
voluntary exercise by emotions or other psychological factors (32).  Central fatigue may 
also be affected by descending motor pathways, interneurons, and motoneurons in the 
central nervous system (brainstem and spinal cord) (32).  A major problem in measuring 
central fatigue is that very little is known about the neurons involved in the generation of 
volitional effort (32).  For this reason most of the experiments designed to test muscular 
fatigue aim to limit the effects of central fatigue, by electrically stimulating muscles rather 
than having the subject perform volitional contractions. 
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 The second component of physiological fatigue is peripheral fatigue (32).  This 
type of fatigue occurs when one or several of the physiological processes that enable 
the contractile proteins to generate force become impaired or reduced (11).  Peripheral 
fatigue occurs outside of the central nervous system and can be caused by reduced 
impulse conduction in the motor axons and their terminals, reduced neuromuscular 
transmission to the muscle, reduced conduction of impulses in the muscle fibers, 
reduced excitation-contraction coupling (E-C coupling), or impairments in the contractile 
process itself (11).  There is no single cause of peripheral muscle fatigue, it can result 
from multiple factors acting at various sites, and a combination of factors can be involved 
(14).  For the duration of this review the term fatigue will imply physiological peripheral 
fatigue.  
 There are several methods that are used to induce and measure muscle fatigue.  
A very common technique is to stimulate the muscle with an external electrical stimulus 
(32).  A muscle twitch is developed by a short burst of electrical activity and has been 
used to evaluate post-fatigued whole muscles and muscle fibers (14).  Some features 
that can be seen in a post-fatigued muscle fiber or whole muscle are:  reduced twitch 
force, reduced whole muscle force, prolonged contraction and half-relaxation times, and 
reductions in the peak rate of tension development (14).   These changes in muscle 
fibers will lead to a decline in muscular performance and will include reduced force 
production, decreased velocity of muscle shortening, and slowed muscle relaxation (2).   
 
Mechanisms of Fatigue 
 Before the mechanisms of fatigue are discussed a review of the events that 
occur to cause muscle contraction will be given.  This process starts in the central 
nervous system that sends an action potential down the α-motoneuron (86).  The action 
potential travels down the motoneurons and reaches the nerve axon terminal, at this 
time voltage-gated Ca2+ channels open and Ca2+ enters the axon terminal (86) .  This 
causes vesicles to migrate to the axon terminal end bud and release the 
neurotransmitter acetylcholine into the synaptic cleft (86).  Acetylcholine reaches the end 
plate of the muscle fiber, binds with postsynaptic receptors, and causes a local 
depolarization (86).  This depolarization causes an action potential on the muscle fiber 
by activating voltage-gated sodium and potassium channels (86).  Next, acetylcholine is 
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removed from the synaptic cleft and the action potential is propagated along the surface 
of the muscle fiber (86).  At this point the process of excitation-contraction coupling (E-C 
coupling) begins.  As an action potential is propagated down the muscle fiber the first 
step of E-C coupling is the action potential moves into the interior of the muscle fiber 
through the T-tubules (32).  This causes the voltage sensors, the dihydropyridine 
receptors (DHPR), to signal the ryanodine receptors (RYRs) to open (32).  When the 
RYRs are open a rapid escape of calcium (Ca2+) from the sarcoplasmic reticulum (SR) 
enters the cytosol of the muscle fiber (32).  Some of the Ca2+ in the muscle fiber cytosol 
combines with troponin on the actin filaments which starts the cross bridge cycle that 
produces muscle shortening and force (32).  Once the action potential has ended, Ca2+ 
is pumped back into the SR by a membrane-bound Ca2+ ATPase and breaks the Ca2+ 
troponin complex which stops the cross bridge cycle (32). 
 Any abnormalities in any of the process just described have the possibility to 
contribute to muscle fatigue.  The mechanisms of fatigue are complex and multiple 
mechanisms can affect muscle fatigue at the same time.  Based on scientific studies it 
has been concluded that muscle fatigue is most likely caused by failure of E-C coupling 
or the reduction of cross bridge force production (32). 
 The first way that fatigue can affect muscle force during E-C coupling is by 
reducing the amount of Ca2+ that is released from the RYR into the muscle fiber cytosol 
(32).  If a smaller amount of Ca2+ is released, then a smaller number of cross bridges will 
be activated.  It has been shown that the concentration of inorganic phosphate (Pi) 
increases in the muscle fiber during muscle contractions (2).  This is because the 
breakdown of phosphocreatine (PCr) to creatine (Cr) and Pi is essential to produce ATP 
rapidly for muscle contraction (2).  It has also been shown that an increase in Pi in the 
muscle fiber reduces Ca2+ release and therefore reduces cross bridge cycling and force 
production (2).  This type of muscle fatigue can be reversed by agents such as caffeine, 
which opens the RYR and allows a greater amount of Ca2+ to enter the muscle fiber (2). 
 Another way that the increased Pi concentration can influence muscle force is by 
slowing down the rate of the membrane-bound Ca2+ ATPase (2).  This will slow down the 
removal of Ca2+ from the muscle fiber back into the SR (2).  This will in turn slow down 
the relaxation rate of the cross bridge cycles and can delay the next cycle which may 
contribute to muscle fatigue (2). 
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 Fatigue can also affect E-C coupling by a reduction in Ca2+ sensitivity (32).  
Reduced Ca2+ sensitivity is a condition where force at a given free Ca2+ concentration is 
lowered (32).  So, in this case it is not the Ca2+ release that is the problem but, it is the 
fact that not as much force is produced from the given Ca2+ release.  In other words it 
would take more Ca2+ release for the same amount of force production.  The 
accumulation of Pi is also thought to reduce Ca2+ sensitivity in a fatiguing muscle (2). 
 Another area that fatigue can influence force production is during the cross 
bridge cycle (14).  It has been shown that there is a slower dissociation of actin from 
myosin in fatigued muscle fibers (14).  This would slow down the rate of contraction of 
the muscle fiber and therefore reduce the force production.  This slowing of cross bridge 
cycling is thought to be caused by an increase in hydrogen ions from the production of 
lactic acid by the contracting muscles, and by the increase of Pi (14). 
 If a muscle fiber does not have ATP then the myosin heads cannot detach from 
the actin molecule and rigor development can set in (84).  This of course does not 
happen in human muscle in vivo (84).  So, it is thought that there may be a safety 
mechanism built into muscles that reduces Ca2+ release when energy consumption can 
no longer be met, to reduce the amount of ATP being consumed and protect the muscle 
from going into rigor (84).  This of course will also decrease the amount of force 
produced and increase the amount of fatigue in the muscle. 
 There have been many hypotheses and theories on what causes muscle fatigue.  
Over the years through different scientific experiments some of these hypotheses have 
been disproven.  But, there has not been one theory that has been proven to explain all 
of the variables involved in muscle fatigue.  There is a way to produce muscle fatigue by 
sub maximal contractions that does not change any metabolite concentration a great 
deal (32).  Based on this and the close correspondence between force and intracellular 
Ca2+ concentration, it has been determined that the likely cause of muscle fatigue occurs 
somewhere in the E-C coupling phase of muscle contraction (32). 
Low-Frequency Fatigue Versus High-Frequency Fatigue 
 Peripheral physiological muscle fatigue can also be sub grouped into two 
different categories based on their physiological mechanisms (35, 37).   These two 
groups are low frequency fatigue at 5 to 30 Hz and high frequency fatigue at 50 to 100 
Hz (35).  High frequency fatigue is induced by high frequency stimulation and is 
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characterized by rapidly recovering loss of force at high frequencies (37).  On the other 
hand low frequency fatigue is induced by low frequency stimulation and characterized by 
long term loss of force at low frequencies (37).  High frequency fatigue recovers very 
quickly usually within minutes after stimulation or exercise has stopped (35).  Based on 
the fast recovery of this type of fatigue the mechanisms are thought to be impaired 
muscle fiber membrane excitation, which is associated with an accumulation of 
potassium in the inter-fiber space or in the extracellular fluid contained in the transverse 
tubular system (35). 
 The second type of peripheral physiological muscle fatigue is low frequency 
fatigue (LFF).  The characteristics of LFF are that muscle force is decreased most 
severely at low stimulation frequencies, recovery of force is slow, taking hours or days, 
and the effects remain in the absence of gross metabolic or electrical disturbance of the 
muscle (2, 3, 25, 35).  This form of fatigue can be seen after any form of intense 
exercise but, is more pronounced after eccentric contractions, and is a large contributor 
to the feeling of weakness in muscles after exercise (25, 84).  Since eccentric 
contractions cause LFF and its very slow recovery, it is possible that it is a consequence 
of some form of damage caused by the generation of high forces within the muscle (22).  
Also, LFF has been induced by voluntary contractions, high frequency stimulation (100 
Hz), and low frequency stimulation (10-40 Hz) (25).  This type of fatigue is typically 
measured by recording torque response to different frequencies of electrical stimulation 
(25).  The change in the ratio of force production with 10-20 Hz stimulation compared to 
the force production with 80-100 Hz stimulation is a fatigue index of LFF that is 
commonly used (25).  Any decrease in this ratio, compared before and after exposure to 
a fatiguing protocol, is interpreted as LFF (25). 
 The primary implication of LFF is the reduction of muscle force at low frequency 
stimulation (25).  Observed force decrements with LFF in human skeletal muscles are 
typically greater than 50% of rested values (25).  Motor unit discharge rates during 
voluntary skeletal muscle activation rarely exceed 30 Hz, so any voluntary muscle 
contraction would be greatly affected by LFF (25).  This would include any strenuous 
activity, walking, stair climbing, and all other activities of daily living (25).  This effect of 
LFF on voluntary muscle contraction could result in higher activation of the central 
nervous system, require the recruitment of a larger number of motor units or increased 
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firing frequency, and cause greater feelings of effort during repetitive activities and may 
limit performance (25). 
 It is clear that the mechanisms of LFF is caused by disruption within the muscle 
rather than in the nervous system because, during LFF the muscle electromyogram 
appears normal and it has been shown to occur in isolated muscle fibers (2).  Also, LFF 
may not have a ionic or metabolic basis like other types of fast recovery fatigue because 
it takes so long to subside (25).  There is evidence that LFF is caused by a defect in E-C 
coupling due to the fact that nearly maximal muscle tension can be achieved by high 
frequency stimulus or the addition of caffeine (2).  The point in E-C coupling that LFF 
may affect is not known but, possible events include:  failure of Ca2+ release from SR, 
reduced Ca2+ sensitivity of the contractile proteins, reduced conduction of the action 
potential in the T- tubules, and reduced Ca2+ reuptake by the SR (25, 84). 
 Westerblad et al. have demonstrated in mouse single muscle fibers that Ca2+ 
sensitivity of the contractile proteins is unchanged and Ca2+ release from the SR is 
reduced at all stimulus frequencies during LFF (84).  They also reported that Ca2+release 
was uniform across the entire muscle fiber, suggesting the T-tubule conduction remains 
adequate (84).  In this experiment Ca2+ reuptake was moderately reduced, but it was 
unlikely to be the cause of the reduced amount of Ca2+ in the muscle fiber (84).  The 
authors concluded that LFF is caused by a reduced Ca2+ release from the SR (84).  This 
reduced amount of Ca2+ from the SR reduces the amount of Ca2+ that can bind to 
troponin, reduces the amount of active muscle fibers, and therefore reduces the amount 
of force that the whole muscle can produce (25).  The reduced Ca2+ release could be 
caused by:  failure of the action potential in the surface membrane, failure of T tubule 
conduction, abnormal function of DHPR in the T tubules, or abnormal function of the 
RYRs (85).  Due to the long time course of recovery of LFF, which suggests that the 
reduced Ca2+ release may last longer than 24 hours, it is likely that a structural change 
involved in E-C coupling occurs and the long recovery time represents repair or 
resynthesis of this change (85). 
 A decrease in Ca2+ release affects muscle tension at low frequencies of 
stimulation to a much greater degree than muscle tension at high frequencies (25, 84).  
This can be seen when the concentration of intracellular Ca2+ release is plotted against 
the muscle tension produced (25).  In this graph it can be seen that the Ca2+ release at 
high frequency stimulation occurs at the plateau of the Ca2+-tension curve so, a change 
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in the intracellular Ca2+concentration would not yield a large change in the amount of 
tension produced by the muscle (25, 84).  On the other hand, low frequency stimulation 
occurs on the steep portion of the Ca2+-tension curve and a small change in the 
intracellular Ca2+ concentration would yield a large change in the muscle tension 
produced (25, 84). 
 It has been shown that the most likely cause of LFF is reduced Ca2+ release from 
the SR (2).  There are many possibilities for the cause of this reduced Ca2+ release and 
the most important evidence that needs to be considered is the long time course of LFF, 
which suggests that reduced Ca2+ release can last for longer than 24 hours (25, 84).  
With this in mind it seems likely that there is some degree of structural damage to one or 
more of the proteins or structures involved in E-C coupling and the long time course of 
LFF represents repair or resynthesis of these proteins or structures (25, 84).  In support 
of this muscle damage explanation it has been shown that LFF is a prominent 
characteristic following eccentric exercises and may be seen during the repair process, if 
the muscle fiber was damaged during this type of contraction (25). 
Eccentric Muscle Contractions and Damage 
 Eccentric muscle contractions are lengthening muscle contractions or stretching 
of contracting muscles and they occur when the imposed load is greater than the muscle 
force generated (2, 45).  Eccentric contractions produce more muscle damage than 
concentric or static contractions (2, 6, 61).  These types of contractions are part of 
everyday normal activities such as, walking downstairs or lowering a heavy weight (2).  
Just walking requires muscles to undergo repetitive cycles of concentric and eccentric 
muscle actions (68).  In general any movement of a joint that is controlled by an agonist 
and antagonist muscle pair, one will be contracting eccentrically and the other will be 
contracting concentrically (2).  In physical activity if there is a large eccentric component 
to the activity, weakness will be apparent during and immediately after the activity but, 
pain, tenderness, swelling and stiffness develop more slowly and last much longer (2).  
These latter symptoms are most prominent on the first or second days after the physical 
activity and they are termed delayed onset muscle soreness (DOMS) (2).  DOMS is 
thought to start with an initial mechanical event, leading to microscopic disruptions within 
the muscle fibers, which then lead to cell membrane damage and the loss of intracellular 
Ca2+ homeostasis (4).  The functional implications of this type of damage caused by 
eccentric muscle contractions are significant and include a decreased joint range of 
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motion, altered fatigability, muscle soreness, and decreased muscle shortening velocity, 
but it is the prolonged strength loss that is the most widely recognized as the largest 
restriction to physical activity (83). 
 After a bout of eccentric exercise muscle soreness appears 24 hours after 
exercise and peaks at 2-3 days post-exercise (9).  Soreness slowly dissipates and does 
not fully subside until 8-10 days after exercise (9).    Swelling and edema have also been 
suggested to cause soreness which is likely due to an increase in muscle pressure (9).  
Muscle strength loss is dramatic immediately after eccentric muscle contractions, 
recovers slowly, and by 10 days after exercise a deficit still remains (9).  This strength 
loss may be caused by damaged myofibrils, a change in neural activation patterns, or 
sarcomeres stretched out by the performance of the lengthening actions (9).  Sarcomere 
length is not uniform over the length of the fiber because, shorter sarcomeres are found 
toward the ends (9).  If the lengthening actions pull some of the central sarcomeres 
apart, the overlap between the actin and myosin filaments would be reduced, which 
would reduce the maximal number of cross bridges, and reduce the amount of force 
production (9).  Another reason that force is reduced after eccentric contractions could 
be the decline of Ca2+ release from the SR (9).  If the SR is damaged due to the 
lengthening contractions Ca2+ release would be reduced and the ability to generate 
normal force levels would be impaired (9).  Immediately after eccentric exercise range of 
motion is decreased and the ability to fully contract the muscle is decreased and is not 
restored until 10 days after the exercise (9).  This could be because of the loss in muscle 
strength and could be related to the overstretched sarcomeres or the decreased Ca2+ 
release from the SR (9).  
 Exercise protocols that use concentric muscle actions typically produce strength 
losses of 10-30% immediately after exercise, with strength returning to baseline within 
hours after exercise (8).  Also, this type of muscle action does not produce damage and 
since there is a fast restoration of force loss, the fatigue is generally considered to be 
due to metabolic or neural factors (7).  On the other hand high force eccentric exercise 
protocols can often generate up to 50-65% loss of force generating capacity when 
compared with pre-exercise values (8).  Prolonged force loss after this type of muscle 
contractions can typically last one to two weeks and is thought to be caused by initial 
damage during the exercise and additional damage during the regeneration process (8). 
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 Maximal eccentric muscle contractions can produce greater output forces than 
concentric and isometric muscle contractions but, they produce lower electromyographic 
(EMG) activity (6).  The amount of integrated electromyographic (IEMG) activity during 
eccentric contractions have been shown to be approximately half that recorded during 
concentric contractions at similar workloads (38).  If the IEMG is taken to reflect the total 
amount of muscle fiber activity, then during eccentric contractions about half the number 
of fibers are being activated to generate a given tension when compared to concentric 
contractions (38).  Muscle damage caused by eccentric muscle contractions has been 
documented directly by muscle biopsy samples and indirectly from losses in strength 
and range of motion, increases in muscle soreness, and increases in muscle proteins, 
such as creatine kinase (CK) and lactate dehydrogenase (LDH), in the blood as markers 
for damage (64).  Among these markers, change in force generating capacity is 
considered to be the most reliable.  As a muscle lengthens, the ability to generate 
tension increases and a higher load is distributed among the same number of fibers, 
resulting in a higher load per fiber ratio (6).  Also, since during eccentric contractions 
there are less active muscle fibers, the load per fiber ratio is increased when compared 
to concentric contractions (11).  The fact that soreness and swelling  peaks 24-48 hours 
post-exercise suggests that the initial damage may be exacerbated in the days after 
exercise (6).  Inflammation occurring after the initial insult is likely responsible for the 
continued damage and may also function in the regeneration process (6). 
 
Rational of HMB Supplementation 
 There have been many different methods and nutritional supplements that have 
been used to attempt to reduce the effects of fatigue, increase fat free mass and 
strength, and improve muscular performance, in an attempt to increase the results of 
physical exercise.  Recreational athletes and health conscious people are looking for a 
way to get more out of their workout sessions to improve their body image or to increase 
their physical fitness level (54).  Billions of dollars are spent each year on nutritional 
supplements and most of these supplements claim to reduce fat mass, increase fat free 
mass, or help to increase muscular strength (58).  The most popular performance 
enhancing supplements are protein and amino acids because they are essential for the 
synthesis of structural proteins and are involved in numerous metabolic pathways that 
are associated with exercise (58).  In particular, a great deal of attention has been paid 
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to the three branched-chain amino acids, leucine, isoleucine, and valine (19).  To 
enhance the increase of muscle mass in the human body in response to an exercise 
stimulus there has to be either an increase in protein synthesis or a decrease in protein 
catabolism (73).  Acute changes in amino acid metabolism caused by exercise are 
largely catabolic with a net negative balance between the rates of protein synthesis and 
protein breakdown (44).  After exercise skeletal muscle remains in negative protein 
balance until adequate protein and energy are available for recovery (44).  This is the 
reason why supplementation with protein and amino acids are very popular with people 
who are active and who are trying to increase their gains from their workout programs.  
Leucine is one of the most popular amino acids that people supplement with because of 
its roles in protein metabolism, glucose homeostasis, insulin action, and recovery from 
exercise (87).   
 During leucine metabolism, it is first transaminated to its ketoacid, α-
ketoisocaproate (KIC) (78).  At this point most of the KIC enters the mitochondria and is 
oxidatively decarboxylated to isovaleryl-CoA by branched-chain α-ketoacid 
dehydrogenase (78).  But, a small amount of KIC (approximately 5%) is converted to β-
hydroxy-β-methylbutyrate (HMB) by KIC dioxygenase in the cytosol of the liver (Figure 
2.4 – left side) (78).  In total only approximately 2 to 10% of leucine oxidation proceeds 
to HMB (13, 73).  HMB is then converted to HMG-CoA which is converted to mevalonate 
and finally cholesterol by the enzyme HMG-CoA reductase (42). 
 In vitro leucine and KIC are both proposed to decrease nitrogen and protein loss 
by inhibiting protein breakdown (40).  Also, leucine has been shown to stimulate protein 
synthesis and inhibit protein degradation in skeletal muscle of intact rats (19).  But, 
animal and human studies have not shown an anabolic effect except in situations of 
either severe stress or trauma in which proteolysis is greatly elevated (40).  This 
suggests that KIC and leucine are active only during periods of excessive catabolism or 
that a further metabolic product of leucine and KIC may be responsible for the 
anticatabolic effects of these compounds (40).  HMB has recently gained attention as a 
nutritional supplement and it claims to increase muscle strength, muscle size, and fat 
oxidation (58, 70, 73, 77, 80, 88).  It has also been associated with increased isometric, 
isokinetic, and dynamic strength and has been generalized across young, elderly, 
untrained, trained and clinically cachexic conditions (88).   
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 HMB is a metabolite of the essential branch chain amino acid leucine and is 
thought to act as an anticatabolic agent, minimizing protein breakdown and damage to 
cells which may occur with intense exercise (17, 21, 26, 46, 49, 50, 53, 55, 57, 58, 73, 
80, 91).  HMB is present in both plants and animal foods such as catfish and citrus fruits 
in small amounts (0.3-0.4 g/d) are produced endogenously (13, 18, 54).  Although HMB 
can be synthesized endogenously from leucine, it would take approximately 60g of 
leucine to reach an HMB dosage of 3 g/d, which is the recommended dosage for HMB 
supplementation (13).  To obtain 60g of leucine from the diet, one would have to 
consume at least 600g of protein from high leucine containing foods such as eggs, dairy, 
and meats (13).  Since this is not practical, to reach higher levels of HMB in the body 
requires nutritional supplementation (13).  When supplemental HMB is consumed, HMB 
peaks in circulation at one to two hours after supplementation and reaches baseline 
levels by nine hours (13).  Also, when HMB is supplemented at 1 to 6 g/d it was shown 
that approximately 14 to 29% was excreted in the urine so, it appears that a majority of 
supplemental HMB remains in the body (13). 
 HMB supplementation has been suggested to impart anticatabolic properties and 
to reduce muscle damage based on reduced enzyme markers of muscle damage such 
as creatine phosphokinase (CK), lactate dehydrogenase (LDH), and 3-methylhistidine 
(3-MH) (17, 21, 55, 70).  Based on this HMB has been hypothesized to be the metabolic 
product of leucine and KIC that is responsible for the anticatabolic effects and to 
facilitate an increase in muscle mass and strength gains when combined with resistance 
training (53, 58). 
Mechanisms of Action of HMB 
 The major claims that are made by promoters of HMB supplementation are that it 
will increase the muscular strength gains and lean muscle mass gains seen during a 
resistance training program (40).  It has been suggested that HMB supplementation 
does this by preventing muscle damage or by regenerating damaged muscle cell 
membranes (26, 43, 46, 53, 66, 88).  This anticatabolic effect has been suggested to be 
achieved by two mechanisms (26, 40, 50).  The first mechanism involves conversion of 
HMB, in the cytosol of the liver, to β-hydroxy-β-methylglutarate-CoA (HMG-CoA) (26, 40, 
50).  HMG-CoA is then employed in cholesterol synthesis and could be rate limiting 
when cholesterol synthesis is in high demand, such as during periods of rapid cell 
growth or membrane repair that is seen with resistance training (17).  Without 
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cholesterol, cells cannot experience normal growth so, most cells are capable of making 
their own cholesterol (90).  But, there are many steps involved in cholesterol 
biosynthesis and much valuable cellular energy is utilized in the complex pathway to 
produce cholesterol (90).  Also, stressed or damaged muscle cells may not be able to 
make sufficient HMG-CoA to support adequate cholesterol synthesis for cell functions 
(41).  Supplemental HMB therefore, may be a source of HMG-CoA in damaged muscle 
cells to maintain adequate cholesterol synthesis and plasma membrane function (41).  It 
has also been proposed that HMB supplementation provides a saturating source of 
cytosolic HMG-CoA for cholesterol synthesis and, in turn, allows for maximal cell growth 
and function (72).  This increase in cholesterol synthesis has not been shown to 
increase blood lipid profiles (41).  In fact, it has been shown that 3 to 8 weeks of HMB 
supplementation decreased total cholesterol by 3.7% and LDL cholesterol by 5.7% (41).  
 The second mechanism is that HMB is polymerized and covalently binds with cell 
membrane structures to enhance membrane integrity (49, 50).  This increased integrity 
may also be accomplished through the additional source of cholesterol provided by HMB 
supplementation (46).  It has been hypothesized that the de novo synthesized 
cholesterol is used to support the cell membrane integrity and help prevent muscle 
damage or used to regenerate damaged muscle cell membranes (26).  Thus, HMB may 
provide the necessary amount of HMG-CoA for cholesterol synthesis and membrane 
protection that would then result in decreased muscle damage and quicker recovery 
from resistance exercise (17).  This is supported by studies that have demonstrated that 
HMB supplementation has decreased markers of muscle damage following strenuous 
exercise (17, 26, 40, 55).  This could also be one reason that HMB supplementation 
does not produce strength gains in subjects that are highly trained with resistance 
exercises (66).  This is because with resistance training protein turnover and resistance 
exercise induced muscle damage are attenuated and HMB supplementation may not be 
able to reduce them further (66).  Also, local deficiencies in muscle cell cholesterol are 
thought to occur due to cell hypertrophy (54).  This could cause cell growth to decrease 
due to inadequate cholesterol available for cell membrane synthesis (54).  Therefore, a 
larger supply of cholesterol for cell membrane synthesis, due to HMB supplementation, 
could lead to further muscle hypertrophy and larger lean muscle gains (54). 
 A more recent review has postulated that HMB supplementation could have other 
mechanisms (91).  These mechanisms include an up regulation of IGF-I gene 
expression in skeletal muscles, stimulation of protein synthesis by increasing the mTOR 
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signaling pathway, and suppression of proteolysis by the inhibition of the UPP system 
(91).  It is established that IGF-I exerts an anabolic action in skeletal muscle, leading to 
hypertrophy of muscle fibers (91).  It has been observed that muscle IGF-I expression 
was increased after a culture of myoblasts were exposed to HMB (13).  It has also been 
reported that IGF-I expression has been increased in whole animal models with HMB 
supplementation (28, 57).  The enzyme mTOR (mammalian target of rapamycin) is a 
protein kinase that is involved in cell growth and HMB appears to act upon the mTOR 
pathway but the mechanisms are not yet known (13, 91).  HMB supplementation may 
attenuate muscle protein losses through reduction of the UPP (91).  The ubiquitin-
proteasome system is up regulated in catabolic states and HMB has been shown to 
decrease the activity of this pathway, thereby possibly reducing protein degradation (13, 
91).  Also, changes in the rates of protein degradation rather than changes in rates of 
protein synthesis are the principle means for altering protein levels in many physiological 
and pathological conditions (73).  These three possible mechanisms of HMB 
supplementation have not been fully researched yet.  Most of these studies have been 
completed in animal models or single muscle fibers (13, 28).  Further research is needed 
into how HMB supplementation may affect muscle growth and protein degradation 
through these three mechanisms. 
 
Research Studies Involving HMB Supplementation 
 A meta-analysis conducted by Nissen and Sharp in 2003 reported that out of 
about 250 substances marketed as dietary supplements, only creatine and HMB were 
found to be effective in augmenting lean tissue gains with resistance training (43).  In a 
second meta-analysis conducted by Rowlands and Thomson it was reported that HMB 
supplementation caused beneficial increases in lower body and overall average strength 
in untrained lifters, and strength was not affected by HMB in trained lifters (65).  In a third 
review article Wilson et al. reported that many studies support the efficacy of HMB as an 
effective ergogenic aid for athletes to decreases DOMS, markers of muscle damage, 
and body fat, while increasing various markers of performance, including lean body 
mass and strength in resistance trained athletes (87).  Also, there were a number of 
studies analyzed that did not support the efficiency of HMB supplementation (87).  The 
authors suggested that the conflicting results may in part be attributed to the variability in 
humans, inadequate sample sizes, and methodological issues such as the specificity of 
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testing conditions, cases of overtraining, elicitation of an inadequate training stimulus in 
experienced participants, limited dependent variables, and short duration experiments 
(87).  But, the results of HBM supplementation does not yield any clear cut conclusions.  
There have been human studies that have reported reduced muscle damage and upper 
body strength gains in both previously untrained men and women (17, 40, 55, 80).  
There have also been studies that have reported increases in muscle mass, muscle 
strength, reduced muscle damage, and anaerobic properties in previously trained men 
and women (26, 58, 77).  HMB supplementation has also been shown to positively affect 
strength, fat free mass, protein synthesis, and functionality in elderly men and women 
(15, 82). 
 Vukovich et al. conducted a study to investigate the kinetics of HMB 
supplementation (81).  Plasma HMB peaked at about 120 nmol/L within 2.0 ± 0.4 hours 
after consumption of one gram HMB and peaked at about 480 nmol/L within 1.0 ± 0.1 for 
three grams of HMB consumed (81).  These values remained stable for the next 90 
minutes, at which there was a gradual decline until 9 hours after consumption at which 
time values were not significantly different from baseline (81).  The percent accumulation 
of HMB in the urine reached a level of about 14% of the given dose following the 
consumption of one gram of HMB and about 29% for a dose of three grams of HMB 
(81).  The authors concluded that with HMB supplementation, plasma HMB levels peak 
between one and two hours and a small amount of HMB is excreted in the urine with the 
remaining being retained in the body for further metabolism (81).  
HMB Used in Cancer and AIDS Research 
 Patients with cancer induced weight loss show a depression of protein synthesis 
in skeletal muscle and an increase in protein degradation, via the UPP pathway (74).  
The cachexia syndrome is seen in a variety of conditions including:  cancer, surgery, 
trauma, sepsis, and AIDS (47).  It is characterized by anorexia, weight loss, weakness, 
anemia, edema, and skeletal muscle wasting (47).  Cancer cachexia has been cited as 
the most frequent cause of morbidity and mortality in patients with cancer and 
maintenance of lean tissue mass should lead to improved survival and decreased 
morbidity (36).  Anabolic stimuli or an increase in calorie intake has been shown not to 
increase lean body weight in cachectic patients which suggests that protein degradation 
must be attenuated before muscle mass can increase (74).  Recent studies have 
indicated that HMB was capable of attenuating protein degradation in skeletal muscle of 
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cachectic mice and also stimulated protein synthesis resulting in an increase in the 
nonfat carcass mass (47, 74).  The reduction in protein degradation was found to be 
caused by down-regulating the increased expression of the UPP pathway in the 
cachectic mice (74). 
 A study conducted by May et al. tested a combination of HMB, L-glutamine, and 
L-arginine supplementation in cancer patients who demonstrated a weight loss of at 
least 5% (36).  It was reported that this combination increased both body mass and fat 
free mass relative to the control group (36).  Also, these changes were apparent as early 
as 4 weeks after the start of supplementation (36).  The authors concluded that this 
combination likely provided the substrates necessary for the body to minimize wasting 
and replenish lean body mass (36). 
 Just like in cancer patients, AIDS patients show a disproportionate loss of lean 
tissue with a preservation of fat mass (5).  Also, these patients consume adequate 
amino acids and energy to support muscle maximal protein synthesis so, the problem of 
wasting is probably due to an accelerated rate of muscle catabolism relative to protein 
synthesis (5).  A study conducted by Clark et al. showed through air displacement 
plethysmography, computerized tomography of leg muscles, and measurements of 
midarm circumferences that a combination of  HMB, L-glutamine, and L-arginine 
increased lean tissue in AIDS-wasted patients (5).  The authors concluded that this 
mixture favorably altered the rates of protein breakdown relative to protein synthesis and 
resulted in net protein accumulation (5). 
 The loss of muscle mass in cancer cachexia appears to be caused by a tumor 
product, proteolysis-inducing factor (PIF), which increases the UPP protein degradation 
pathway (75).  In two separate studies it was reported that HMB was an effective agent 
for the management of muscle wasting in cancer induced protein degradation in murine 
myotubes (10, 75).  It was concluded in both studies that HMB produced these positive 
effects by attenuation of PIF-induced protein degradation mediated through the UPP 
pathway (10, 75). 
Research Studies That Reported No Effects of HMB Supplementation 
 Not all research studies have shown favorable results associated with HMB 
supplementation.  In general authors have reported that HMB supplementation did not 
have an effect on muscular strength, muscular endurance, or body composition in 
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trained males (49, 50, 70).  Also, short supplementation of HMB (less than 14 days) did 
not show any benefit in recovery of muscle function after exercise induced muscle 
damage or any other ergogenic responses in previously trained or untrained males (21, 
46, 53). 
 There were five research studies found that used trained subjects and reported 
no effects of HMB supplementation (Table 2.1).  The first of these studies was 
conducted by Ransone et al. and used Division I college football players as subjects 
(62).  The subjects in this study supplemented with 3g per day of HMB for 28 days (62).  
During the supplementation period the subjects participated in a strength training and 
cardiovascular training program four days per week (62).  Strength exercises were 
performed at 10 exercises per session, with 8-12 sets per exercise and 2-10 repetitions 
per set (62).  The authors reported that HMB supplementation did not alter muscular 
strength, total body weight, or percent body fat in collegiate football players undergoing a 
exercise program (62).  It was concluded that HMB may be most effective when initiating 
an exercise training program or increasing the workload of a training program (62). 
 The second HMB research study that involved trained athletes was conducted by 
O’Connor and Crowe and elite male rugby players were used as subjects (50).  In this 
study aerobic power was tested using a 20 meter shuttle test and anaerobic capacity 
was measured using a 60 second maximal cycle ergometer test (50).  Pre and post-
supplement measurements were separated by six weeks and the dosage was 3g per 
day (50).  It was reported that HMB supplementation did not alter aerobic or anaerobic 
power in the subjects (50). 
 O’Connor and Crowe conducted another study using elite male rugby players 
and HMB supplementation and used the same dosage and supplementation time period 
(48).  In this study muscular strength and endurance, leg power, and anthropometry 
were measured pre and post-supplement (48).  The authors reported no improvement in 
muscular strength and endurance, leg power, or anthropometry with HMB 
supplementation during a resistance training program (48).  The authors concluded that 
the benefits from HMB may be limited in well trained subjects, particularly those with a 
resistance training background (48). 
 A study conducted by Kreider et al. examined the effects of HMB 
supplementation during resistance training on markers of catabolism, body composition, 
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and strength in experienced resistance trained males (29).  The supplementation period 
was 28 days and the dosage of HMB was 0, 3, or 6g per day for this study (29).  Pre and 
post supplementation measurements were taken and consisted of body composition, 
venous and urine samples, and bench press and leg press maximal lifts (29).  The 
authors reported that no dosage of HMB affected markers of anabolic/catabolic status, 
body composition, or gains in upper and lower body strength (29). 
 Slater et al. conducted a study with resistance trained males and 6 weeks 
supplementation of 3g per day of HMB (69).  Pre and post supplementation 
measurements were taken and consisted of body composition, venous blood sample, 
and 3 repetition maximum strength tests in the bench press, leg press, and chin-ups 
(69).  It was reported that HMB did not influence changes in strength or body 
composition during resistance training in strength trained subjects (69). 
 A second group of studies were found that reported HMB supplementation did 
not have any benefits and these studies all had supplementation periods less than 14 
days (Table 2.1).  The first of these studies was conducted by Paddon-Jones et al. and 
the HMB supplementation was 40mg/kg bodyweight/day for 6 days (52).  The exercise 
protocol for this study was 24 maximal voluntary eccentric contractions of the elbow 
flexors and pre and post-test measurements were taken (52).  The measurements used 
in this study were muscle soreness, upper arm girth, and isometric, concentric, and 
eccentric torque (52).  The authors reported that short-term supplementation with HMB 
did not reduce the severity of muscle soreness or improve the recovery of muscle torque 
following an acute bout of eccentric exercise (52). 
 Another short-term HMB supplementation study was conducted by Hoffman et al. 
(20).  In this study Division III college football players supplemented with 3g per day 
HMB for 10 days during their preseason football training camp (20).  Pre and post-
supplementation measures were taken and included blood samples measured for 
testosterone, cortisol, myoglobin, and creatine kinase, and a 30 second Wingate 
anaerobic power test was used to measure peak power, mean power, and rate of fatigue 
(20).  The authors reported that short-term HMB supplementation did not attenuate 
biochemical markers of muscle damage or improve anaerobic power in college football 
players (20).   The authors concluded that if HMB has any ergogenic benefit in 
attenuating muscle damage, it is likely to be most effective in the untrained population 
where the potential for muscle damage to occur during exercise is greatest (20). 
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 A third short-term HMB supplementation study was conducted by Nunan et al. 
and subjects supplemented for 14 days with 3g per day HMB (46).  Post-test measures 
were taken 24, 48, and 72 hours after a 40-minute downhill run and consisted of mid-
thigh girth, knee extensor range of motion, serum CK activity, isometric and concentric 
torque, and a DOMS measure (46).  The authors reported that HMB supplementation 
had no effect on any of the indices of muscle damage but, there was a trend for a more 
rapid recovery of isometric function (46).
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 Table 2.1:  Summary of Studies that Reported no Effects of HMB Supplementation 
Authors Subjects Exercise Protocol Supplementation 
Duration 
Dosage Outcome Measurements Findings 
Ransone et al. 
(62) 
35 College 
football 
players 
Strength training:  
8-12 sets, 2-10 
repetitions for 
each exercise 
28 Days 3g Per day 1) 3-5 Repetition maximum lifts:  
Bench press, power cleans, squats 
2) Body composition:  3 site 
skinfold 
1) HMB did not alter muscular 
strength, total body weight, or 
percent body fat 
O’Connor and 
Crowe (50) 
27 
Professional 
rugby players 
Pre and post 
measurements 
only 
6 Weeks 3g Per day 1) 20 meter shuttle aerobic power 
test 
2) 60 second cycle anaerobic 
capacity test with blood lactate 
1) HMB did not alter aerobic or 
anaerobic power 
O’Connor and 
Crowe (48) 
30 
Professional 
rugby players 
Pre and post 
measurements 
only – Subjects 
continued normal 
workout program 
6 Weeks 3g Per day 1) 3 Repetition maximum:  bench 
press, deadlift, shoulder press, 
prone row 
2) Leg power:  10s maximal cycle 
ergometer test 
3) Anthropometric profile 
1) HMB did not alter muscular 
strength and endurance, leg power, 
or anthropometry 
Kreider et al. 
(29) 
40 Resistance 
trained males 
Pre and post 
measurements 
only – Subjects 
continued normal 
workout program 
28 Days 0, 3, or 6g Per 
day 
1) Venous and urine sample 
2) Maximum strength tests:  Bench 
press, leg press 
3) Body composition 
1) HMB did not affect markers of 
anabolic/catabolic status, body 
composition, or upper and lower 
body strength 
Slater et al. 
(69) 
27 Resistance 
trained males 
Pre and post 
measurements 
only – Subjects 
continued normal 
workout program 
6 Weeks 3g Per day 1) Venous blood sample 
2) Body composition 
3) 3 repetition maximum strength 
tests:  Bench press, leg press, 
chin-ups 
1) HMB had no influence on 
strength gains or body composition 
Paddon-Jones 
et al. (52) 
17 Non-
resistance 
trained males 
24 Maximal 
voluntary 
eccentric 
contractions of the 
elbow flexors 
6 Days 40mg/kg 
bodyweight/day 
1) Muscle soreness 
2) Upper arm girth 
3) Isometric, concentric, and 
eccentric torque 
1) Short-term HMB did not reduce 
muscle soreness or improve 
recovery of muscle torque following 
an acute bout of eccentric exercise 
Hoffman et al. 
(20) 
26 Division III 
college 
football 
players 
Preseason 
football training 
camp 
10 Days 3g per day 1) Blood measures:  Testosterone, 
cortisol, myoglobin, creatine 
kinase 
2) Anaerobic power performance:  
30 sec Wingate test 
1) HMB did not attenuate markers 
of muscle damage or improve 
anaerobic power performance 
Nunan et al. 
(46) 
14 Male 
recreational 
exercisers 
40-minute 
downhill run 
14 Days 3g per day 1) Mid-thigh girth 
2) Knee range of motion 
3) Serum CK activity 
4) Isometric and concentric torque 
5) DOMS measurement 
1) HMB had no effect on indices of 
muscle damage 
2) There was a trend for a more 
rapid recovery of isometric function 
with HMB 
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Research Studies That Reported Positive Effects of HMB Supplementation 
 HMB supplementation has been claimed to enhance gains in strength and lean 
body mass associated with resistance training and it has been suggested to accomplish 
this through a reduction in skeletal muscle damage (73).  Because of this the research 
studies that have reported positive effects of HMB are grouped into two categories, ones 
that show a decrease in muscle damage and ones that show an increase in muscular 
strength or lean body mass (Table 2.2). 
 The first study to report a decrease in muscle damage caused by HMB 
supplementation was conducted by Ostaszewski et al. and rat and chicken whole 
muscles were used in vitro (51).  This study did not utilize an exercise protocol rather; 
protein synthesis and breakdown were measured in whole muscles (51).  The authors 
reported that HMB decreased proteolysis in both rat and chicken muscles but did not 
affect protein synthesis in either group (51). 
 A human resistance training study with HMB supplementation was conducted by 
Panton et al. (56).  In this study both males and females were used and they were 
grouped into a trained or untrained groups (56).  In the male group creatine 
phosphokinase (CK), which is a marker for muscle damage, increased only 3.7% from 
baseline in the HMB group but, showed a 15.2% increase in the placebo group during 
the exercise protocol (56).  For females, the difference in plasma CK was greater 
between the HMB supplemented and placebo groups, with the HMB group decreasing 
by 12.8% and the placebo increasing by 46.9% from baseline (56).  In the male cohort 
the HMB group had a greater increase in upper body strength compared to the placebo 
(placebo 7.0 kg and HMB 9.9 kg; p  0.05) and the female HMB group showed a trend 
toward a greater increase in upper body strength compared to the placebo (placebo 3.2 
kg and HMB 5.1 kg; p=0.065) (56).  The authors reported that the response from HMB 
does not appear to be dependent on previous training levels and both males and 
females appear to respond to HMB supplementation (56).  The authors concluded that 
both males and females in the HMB group, tended to have lower CK levels than the 
placebo group indicating that less cell membrane damage may have occurred (56).  It 
has been postulated that supplementation with HMB can provide a source of HMG-CoA 
for cholesterol synthesis and this cholesterol is an important constituent of cell 
membranes (56).  Therefore, supplementation with HMB may lead to increased 
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membrane integrity by supplying a source for increased synthesis of intracellular 
cholesterol during a time of need (56). 
 Van Someren et al. conducted a study using non-resistance trained males and 
supplemented with both HMB and KIC for 14 days (79).  The subjects performed an 
exercise protocol designed to induce muscle damage using single arm biceps curls and 
outcome measurements were taken at:  pre-exercise, and 1h, 24h, 48h, and 72h post-
exercise (79).  It was reported that there was a significant difference between HMB/KIC 
and placebo groups for the percentage change in 1 repetition maximum in the biceps 
curl (P ≤ 0.05) (79).  Also, there was a significant difference in the CK response between 
the groups, which increased over the 48h following exercise in the placebo group but, in 
the HMB/KIC group CK levels showed very little increase after exercise (79).  The 
percentage increase in limb girth was attenuated in the HMB/KIC group over the 72h 
post-exercise period and it returned to pre-exercise levels faster than the placebo group 
(79).  Finally, DOMS was significantly lower at 24h post-exercise in the HMB/KIC group 
when compared to the placebo group (79).  The authors concluded that HMB and KIC 
supplementation attenuated muscle damage in non-resistance trained males following a 
single bout of eccentric resistance exercise (79).  Also, HMB/KIC had a significant effect 
on the percentage decrement in muscle function demonstrated by a greater decrement 
in 1 repetition maximum strength in the placebo group over the recovery period (79).  
The attenuated CK response in the HMB/KIC group indicated that muscle damage was 
reduced following the exercise protocol, perhaps via enhanced cell membrane integrity 
(79). 
 Knitter et al. examined the effects of HMB supplementation on muscle damage 
after a prolonged run (27).  After 6 weeks of supplementation subjects completed a 
20km run and plasma creatine phosphokinase (CPK) and lactate dehydrogenase (LDH) 
activity were measured as markers of muscle damage (27).  The HMB group 
experienced a significantly lower CPK response (P = 0.05) and lower LDH levels (P = 
0.003) compared with the placebo group over the 4 days after the prolonged run (27).  
The authors concluded that because both groups performed equally well in the 
prolonged run, the larger increases in enzyme activity in the placebo group suggest that 
they sustained more muscle damage as a result of the run (27).  These findings are 
consistent with the hypothesis that HMB supplemented subjects experienced less 
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muscle damage or that they recovered from muscle damage at a faster rate when 
compared to a placebo group (27). 
 Another study that examined HMB supplementation during a resistance training 
program was conducted by Nissen et al. (39).  In this study three groups of subjects 
weight lifted for 3 weeks and supplemented with either 0, 1.5, or 3g per day of HMB (39).  
The authors reported that the increase in lower body weight lifted during the study was 
greater in the HMB groups than in the unsupplemented group (P < 0.01) (39).  The 
unsupplemented subjects increased the number of abdominal efforts by 14% during the 
3 weeks, whereas both HMB groups increased the number of abdominal efforts 
approximately 50% over the 3 week study (P < 0.05) (39).  Also, after one week of 
exercise urinary methylhistidine (MH), a marker for muscle damage, increased 94% in 
subjects not supplemented with HMB, 85% in subjects supplemented with 1.5g HMB, 
and 50% in subjects supplemented with 3g HMB (39).  In week two MH was 27% above 
basal level in the control group, and 4 and 15% below the basal level for the 1.5 and 3g 
HMB groups (39).  During the third week of the study, HMB did not have a significant 
effect on MH (39).  The authors concluded that these changes suggest that HMB 
prevents or slows muscle damage as well as partially preventing the increase in 
proteolysis associated with intense muscular work (39).  
 The second group of research studies that have reported positive effects of HMB 
supplementation are ones that have reported increases in strength and/or increases in 
fat free mass (Table 2.2).  The first of these studies was conducted by Pinheiro et al. and 
evaluated the effects of HMB supplementation for 4 weeks upon metabolic parameters 
and skeletal muscle contractile function in rats (57).  It was reported that HMB 
supplementation increased muscle tetanic force by 18.2% (P = 0.042) and increased the 
resistance to acute fatigue in the gastrocnemius muscle (P < 0.05) (57).  Since fatigue 
has been associated with increased muscle damage induced by contractile activity, the 
authors suggested that HMB supplementation decreased exercise induced muscle 
damage, due to its increased resistance to acute fatigue (57).  This protective effect of 
HMB against contractile activity induced damage may be associated to increased 
stability of muscle plasma membrane (57).  The authors concluded that HMB 
supplementation is associated with increased intrinsic force capacity of single skeletal 
muscle fibers and prevention of acute muscle fatigue (57). 
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 Gallagher et al. employed an 8 week supplementation period with either 0, 3, or 
6g of HMB per day during a resistance training program to determine whether a higher 
dose of HMB provided any additional benefits (16).  It was reported that HMB 
supplementation elicited no differences in one repetition maximum strength compared 
with the placebo group (17).  But, the 3g per day HMB group improved isometric knee 
extension torque by 32% which represented a greater improvement than the 0 and 6g 
per day groups (P < 0.05) (16).  The CK values taken at 48h after the initial exercise 
bout were increased in the 0g per day group when compared to the other two groups (P 
< 0.05) (16).  Also, the 3g per day group demonstrated a greater increase in fat free 
mass (1.9kg) from pre to post-training than the other two groups (P < 0.05) (16).  The 
authors concluded that HMB supplementation appears to increase peak isometric 
torque, and fat free mass, and decrease plasma CK activity (16).  Also, higher doses of 
HMB (6g per day) do not promote greater strength or fat free mass gains (16). 
 Portal et al. assessed the effect of 7 weeks of HMB supplementation on elite 
male and female junior volleyball players during the initial phase of the training season 
(59).  It was reported that HMB supplementation resulted in a significantly greater 
increase of fat-free mass (P = 0.00), significantly greater decrease in percent body fat (P 
= 0.04) and a significantly greater strength gain in 6 repetition maximum bench press (P 
= 0.00) and leg press (P = 0.00) (59).  HMB supplementation also resulted in a 
significant greater increase in peak (P = 0.00) and mean (P = 0.00) anaerobic power 
(59).  The authors concluded that HMB supplementation was associated with a greater 
increase in muscle mass, muscle strength, and anaerobic properties in elite male and 
female adolescent volleyball players (59).  
 A study conducted by Thomson et al. determined the effects of nine weeks of 
HMB supplementation during a resistance training program on the strength and body 
composition of resistance trained males (76).  It was reported that HMB supplementation 
substantially increased leg extension strength (9.1 ± 7.5 kg, P = 0.05) but, the effect on 
bench press (-1.9 ± 9.3kg, P = 0.72) and bicep preacher curl (-1.7 ± 4.7 kg, P = 0.51) 
was unclear (76).  Also, the overall combined lift strength was trivial (1.6 ± 4.3 kg, P = 
0.52) (76).  The increase in body mass (P = 0.35) and fat free mass (P = 0.84) were 
negligible (76).  The authors suggested that if HMB acts via accentuating cholesterol 
synthesis and is used as a structural component of cell membranes, it may support 
membrane function that is essential for excitation and optimal contractile performance 
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during resistance exercise (76).  The authors concluded that HMB supplementation in 
conjunction with resistance training may result in meaningful improvements in lower 
body strength and benefits to lean mass are unlikely, but small reductions in fat mass 
are possible in resistance trained males (76).
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Table 2.2:  Summary of Studies that Reported Positive Effects of HMB Supplementation 
Authors Subjects Exercise Protocol Supplementation 
Duration 
HMB Dosage Outcome Measurements Findings 
Ostaszewski 
et al. (51) 
Rat and 
chicken whole 
muscles 
None – Protein 
synthesis and 
breakdown were 
measured 
Muscles 
incubated in 
HMB solution for 
2 hours 
Muscles 
incubated in 
1mM HMB 
solution 
1) Protein synthesis 
2) Protein breakdown 
1) HMB inhibited proteolysis 
Panton et al. 
(56) 
43 Males and 
41 females – 
Trained and 
untrained 
groups 
Resistance training – 4 
weeks, 3 times per 
week, 3 sets of 3-6 
repetitions 
4 Weeks 3g per day 1) Plasma creatine phosphokinase 
2) Body composition 
3) Strength tests – 1 Repetition maximum – 
Bench press, leg press, leg extension 
1) Both males and females respond to HMB  
2) HMB response did not appear to be 
dependent on previous training levels 
Van 
Someren et 
al. (79) 
6 Non-
resistance 
trained males 
3 sets of 10 repetitions 
of single arm eccentric 
biceps curls at 70% 1 
repetition maximum 
14 Days HMB - 3g per 
day 
KIC – 0.3g per 
day 
1) Concentric 1 repetition maximum 
2) Plasma creatine kinase activity 
3) Muscle soreness (DOMS) 
3) Limb girth 
4) Range of Motion 
1) HMB and KIC attenuated muscle damage  
2) HMB/KIC attenuated increase in creatine 
kinase, DOMS, and limb girth 
Knitter et al. 
(27) 
8 Males and 8 
Females 
20km prolonged run 6 Weeks 3g per day 1) Maximal oxygen consumption (Vo2 max) 
2) Body composition 
3) Plasma creatine phosphokinase 
4) Lactate dehydrogenase 
 
1) HMB group showed lower levels of 
creatine phosphokinase and lactate 
dehydrogenase when compared to a placebo 
group 
Nissen et al. 
(39) 
41 Males Resistance training – 3 
days per week, 3 sets 
of 3-5 repetitions 
3 Weeks 1.5g or 3.0g 
per day 
1) Methylhistidine activity 
2) Lactate dehydrogenase 
3) Body Composition 
4) Fat free mass 
1) HMB groups increased abdominal 
exercises and lower body weight lifted to a 
greater degree 
2) HMB groups had smaller methylhistidine 
activity increases 
Pinheiro et 
al. (57) 
24 Male 
Wistar rats 
None – Pre and post 
supplementation 
measures only 
4 Weeks 320 mg/kg per 
day 
1) Muscle twitch force 
2) Tetanic muscle force 
1) HMB increased tetanic forces by 18.2% 
2) HMB increased resistance to acute fatigue 
in the gastrocnemius muscle 
Gallagher et 
al. (16) 
37 Untrained 
males 
Resistance training – 3 
sets of 10 repetitions 
and a final set to 
failure 
8 Weeks 0, 3, or 6g per 
day 
1) Maximal isometric contractions 
2) Concentric and eccentric isokinetic 
evaluation 
3) Fatigue evaluation 
4) Plasma creatine phosphokinase 
5) Body composition 
1) HMB elicited no differences in one 
repetition maximum  
2) 3g per day HMB group improved isometric 
knee extension torque 
3) 3g per day HMB group had a greater 
increase in fat free mass 
Portal et al. 
(59) 
15 male and 
14 female 
elite junior 
volleyball 
players (13.5 – 
18 years old) 
- Resistance training – 
65-75% of one 
repetition maximum 
- Endurance training – 
long distance running 
7 Weeks 3g per day 1) Body composition 
2) Muscle strength – Upper and lower body 
6 repetition maximum tests 
3) Anaerobic power – 30s Wingate test 
4) Aerobic power – 20 min shuttle run test 
5) Hormones and inflammatory mediators 
1) HMB was associated with a greater 
increase in muscle mass, muscle strength, 
and anaerobic properties 
Thomson et 
al. (76) 
22 Resistance 
trained males 
Resistance training – 3 
sessions per week, 2-3 
sets, 5-15 repetitions 
9 Weeks 3g per day 1) Strength – 1 repetition maximum – Bicep 
curl, bench press, leg extension 
2) Body composition 
1) HMB increased leg extension strength 
2) Overall combined lift strength was trivial 
3) Increase in body mass and fat-free mass 
was negligible 
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 Even though there cannot be any clear cut conclusions drawn from the current 
research on HMB supplementation, there can be some general guidelines drawn.   Most 
of the studies used a dosage of 3g per day for HMB supplementation and it appears that 
short term use and increased dosing are not useful (54, 73).  Inconsistent gains in upper 
vs. lower body strength have been observed with the majority of the improvements being 
in lower body strength (66).  Supplementation gains may also be related to the training 
status of the subjects involved, with greater gains more likely seen in less trained 
subjects (54).  There is a pattern for reduction in markers of muscle damage with HMB 
supplementation but, the magnitudes are variable (66).  It is believed that HMB 
supplementation exerts positive effects in conditions in which muscle proteolysis is more 
pronounced, such as sedentary individuals and persons with AIDS or cancer (54, 91).  
Also, the type of muscle contraction may play a role in the amount of gains that are seen 
with HMB, with eccentric contractions seeing more gains, due to higher muscle tension 
and greater muscle damage (91).  There have been no adverse effects on hematology, 
or hepatic or renal function with HMB supplementation and some studies reported a net 
decrease in total cholesterol, low density lipoprotein cholesterol, and systolic blood 
pressure (18, 43).  Also, at this time HMB is currently not banned from any federal, 
international, or other sporting organizations (54). 
Conclusion 
 Peripheral physiological muscle fatigue is a problem that affects many other 
people besides athletes and those partaking in exercise programs.  Muscle fatigue can 
affect those suffering from long term illnesses such as AIDS and cancer or even young, 
middle, and older aged adults completing their activities of daily living.  The mechanisms 
of muscle fatigue are not know for sure but, most current research points to a defect in 
E-C coupling as the main source of muscle fatigue.  This E-C uncoupling is the main 
cause of reduced muscle force and LFF which can last for several days.  This LFF is 
most often caused by eccentric muscle contractions which cause more muscle damage 
than concentric or isometric contractions.  Eccentric contractions affect everyone 
everyday of their lives.  Just walking on a level surface involves a great deal of eccentric 
muscle contractions.  If someone engages in an increase of eccentric contractions such 
as increased walking, walking downhill, or a more structured exercise program it is very 
likely they will experience increased muscle damage and increased LFF.  If a nutritional 
supplement can be used to reduce this muscle damage, caused by eccentric muscle 
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contractions, then the decreased force production of LFF can be avoided.  HMB 
supplementation has been suggested and shown to reduce muscle damage during 
activity.  If supplementation with this substance can be shown to reduce LFF caused by 
eccentric muscle contractions then it may provide quicker recovery from physical activity 
for recreational athletes, the general public, and people suffering from long term 
illnesses.  
 Some studies demonstrate that HMB has the ability to increase strength gains 
and fat free mass gains during a resistance training program.  It may accomplish this 
through reducing the amount of muscle fatigue after one bout of physical activity, 
allowing the muscle to perform more work in a repeated bout of activity, therefore 
producing a greater training effect and greater gains in strength and fat free mass.  But, 
to date there have not been any studies determining HMB’s ability to reduce muscle 
fatigue after a bout of physical activity.  Also, there does seem to be reduced markers of 
muscle damage with HMB supplementation (17, 40, 55, 80).  So, HMB supplementation 
may be effective in reducing LFF caused by muscle damage.  To this date a research 
study has not been found investigating the effects of HMB supplementation and the 
reduction of LFF.  Studies have shown that there are changes to rapid muscle force 
characteristics after a bout of physical activity.  But, there have not been any studies that 
have tried to reduce these changes through nutritional supplements or any other means.  
So, future research should be focused on HMB’s ability to reduce changes in rapid 
muscle force characteristics and long term muscle fatigue. 
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Chapter III:  Methodology 
Subjects 
 A total of 33 healthy recreationally active (physically active for 60 mins per day 3-
5 days per week) young (18-35 yrs old) adults (15 women and 18 men) participated in 
this study.  After providing written informed consent approved by the University of 
Kentucky Office of Research Integrity Medical Institutional Review Board, each subject 
filled out a Physical Activity Readiness-Questionnaire and Health History Form to identify 
any existing contraindications to the testing procedures as specified in the American 
College of Sports Medicine Guidelines for Exercise Testing and Prescription (1).  
Additional contraindications to inclusion in this study were previous lower limb orthopedic 
injuries and/or limitations prohibiting completion of the muscle testing or fatiguing 
protocols included in this investigation. 
Testing Procedures 
 Prior to all pre and post supplementing muscle testing sessions, all subjects 
completed a familiarization session. This was followed by scheduling and completion of 
the anthropometric and body composition measurement testing, Pre-Supplement 
baseline session with fatigue protocol, Pre-Supplement 48 hour recovery session, and 
Pre-Supplement 96 hour recovery session.  The Pre-Supplement measures were 
performed on a randomly selected lower limb of each subject.  Identical testing 
procedures were then performed on the opposing lower limb following 3 wks of 
supplementation.  This supplementation consisted of a 1 gram tablets consumed 3 times 
daily (morning, mid-day, and evening) of calcium β-Hydroxy-β-Methylbutyrate (HMB), for 
a total of 3 grams per day.  The Post-Supplement testing provided Post-Supplement 
baseline session with fatigue protocol, Post-Supplement 48 hour recovery session, and 
Post-Supplement 96 hour recovery session, thus allowing a repeated measures between 
lower limb muscle testing study design. During each testing period maximal voluntary 
isometric contraction (MVC), peak twitch torque, 10/50 Hz ratio stimulation, and EMG 
measurements were taken.  After the baseline with fatigue protocol session the subject 
returned on two more occasions at approximately 48 and 96 hours after the fatigue 
protocol to complete the recovery measurements.  While participating in this study, 
subjects were asked to maintain their current exercise and dietary patterns and to 
abstain from other nutritional supplements and energy drink consumption. Twenty-four 
hours prior to Pre and Post Supplement baseline sessions with fatigue protocol, subjects 
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were asked to refrain from nonprescription drugs, exercise, alcohol, energy drink 
consumption, and caffeine.  
Anthropometric and Body Composition Measurements.  Standing height and body 
weight were determined for each subject using a wall-fixed stadiometer (Seca 
Statiometer Pat. No. 4694581) and a calibrated scale (Teraoka D1-10; Singapore), 
respectively.  A total body dual energy x-ray absorptiometry (DXA) scan was performed 
on each subject using a Lunar Prodigy (Lunar Inc., Madison, WI) densitometer to 
determine relative adiposity (%Fat).  All scans were analyzed by a single trained 
investigator using Lunar software version 14.10.  In addition, range of motion 
measurements of the ankle were taken using a transparent plastic goniometer (Baseline, 
Diagnostic and Measuring Instruments, White Plains, NY) immediately prior to the 
muscle testing performed on Pre-and Post-Supplement baseline sessions, 48 hour 
recovery sessions, and 96 hour recovery sessions.  
Pre and Post Supplement Baseline Session with Fatigue Protocol 
 Each baseline session with fatigue protocol was preceded by a 5 min low-
intensity warm-up performed on a recumbent cycle ergometer.  This was followed by 
baseline isometric skeletal muscle strength (MVC) and skeletal muscle activation 
measures (EMG).  Electromyography was used simultaneously throughout the skeletal 
muscle measures.  Following the Pre and Post Supplement baseline measures, a 
muscle fatigue protocol was implemented followed by identical isometric skeletal muscle 
strength, skeletal muscle activation and EMG measures.  This process of imposing a 
muscle fatiguing protocol followed by skeletal muscle strength, activation and EMG 
measures was repeated a total of 4 times (4 sets of 25 repetitions) with 15 seconds rest 
between fatiguing and measurement sets.  To complete Pre and Post Supplement 
baseline session with fatigue protocol, muscle strength, muscle activation and EMG 
measures were again taken at 2, 5, 10, 15, and 20 mins following the final fatiguing bout 
to determine the acute recovery measures.  
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Figure 3.1:  Study Overview  
 
 
Figure 3.2:  Pre and Post- Supplement Baseline and Fatigue Protocol Session Overview 
 
 
Isometric Skeletal Muscle Strength 
 Isometric strength of the tibialis anterior was obtained from the Biodex Multi-Joint 
System 4 isokinetic dynamometer (Biodex Medical Systems, Shirley, NY) with the 
Biodex Advantage software version 4.0. All isometric tests were administered by a single 
trained investigator.  Participants sat in a slightly reclined position with the hip, knee, and 
ankle angles set at 100, 140, and 30 degrees plantar flexion.  The participants were 
stabilized with 2 shoulder straps, a waist strap, and a thigh strap.  All voluntary and 
evoked isometric contractions were performed at an ankle joint angle of 30 degrees of 
plantar flexion.  Before testing, familiarization with the equipment and testing procedures 
were completed by having the participant perform three submaximal contractions on 
each strength test.  For the test procedures, each participant was asked to complete 
three nonconsecutive maximal isometric contractions (ankle joint angle of 30 degrees 
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plantar flexion).  There were 120 seconds rest between each maximal isometric 
contraction.  Each participant was instructed to exert maximal voluntary effort by 
contracting as hard and as fast as possible during the isometric contractions.  The 
highest contraction amplitude value of the three attempts for each exercise was 
recorded and used in the subsequent analyses. 
Electromyography 
 To monitor changes in muscle electrical activity during isometric strength testing 
and the development of fatigue, electromyographic signals were collected.  Prior to 
electrode placement, the skin was shaved of any hair and cleaned with pre-soaked 
alcohol swabs.  Surface electrodes (Delsys system Bagnoli DE-2.1 single differential 
electrodes, inter-electrode distance 10 mm, bandwidth 20-450 Hz, Natick, MA) were 
placed on the tibialis anterior ( ~ 7 cm distal to the tibial tuberosity and ~ 2 cm lateral to 
the tibial anterior border) and soleus muscles ( ~ 2 cm distal to the medial head of the 
gastrocnemius).  Data was collected using the Delsys Bagnoli 8-channel digital interface 
(Model number:  DS-B03, Natick, MA).  The gain setting was 1000 Hz and the sampling 
rate was 1000 Hz.  The ground electrode was place on the patella of the limb that was 
not being tested.  At the peak of each MVC the root mean squared value was recorded 
for one second.  In addition, all raw EMG data was smoothed with a fourth order 
Butterworth filter. 
Skeletal Muscle Activation 
 Stimulated contractions of the dorsiflexors were evoked electrically with two 
round carbon rubber electrodes (3 cm diameter; Medi-Stim, Wabasha, Minnesota, USA), 
positioned at the optimal site for twitch torque.  The anode was positioned anterior, and 
the cathode 2-3 cm inferior to the tibial tuberosity over the deep branch of the common 
fibular nerve.  A computer-triggered stimulator (model DS7AH, Digitimer, WelwynGarden 
City, Hertfordshire, UK) set at 400V provided the electrical stimulation using a pulse 
width of 100 ms. 
 Peak twitch torque was determined by increasing the current until a plateau in 
dorsiflexor peak torque was reached and then the current was further increased by at 
least 15% to ensure supramaximal stimulation was achieved.  This stimulation intensity 
was used to evoke a twitch (on pulse) and a doublet (two pulses at a 10 ms interpulse 
interval) to assess potentiation and voluntary activation, respectively.  Peak 50Hz torque 
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was determined by increasing the current until a plateau in dorsiflexor peak torque was 
achieved.  Prolonged low-frequency force depression was accessed via the 10Hz (5 
pulses over 0.5s) and 50Hz stimulus (25 pulses over 0.5s) peak torque ratio. 
 
Fatigue Protocol 
 All voluntary and evoked isometric dorsiflexion contractions were performed at an 
ankle joint angle of 300 plantarflexion (PF) (21).  Eccentric or lengthening contractions 
began at the neutral ankle angle (00 PF) and continued until 30 degrees of plantarflexion.  
The fatigue protocol consisted of 4 sets of 25 eccentric isokinetic dorsiflexion 
contractions at 300/s through a 30 degree range of motion with each set separated by ~ 
30 s of rest (21).  Dominate or non-dominate lower limb was randomized.  During this 
fatigue protocol EMG measurements were recorded.  Immediately after the last set, the 
post fatigue measurements were taken and consist of:  MVC peak torque,peak twitch 
torque, and 10/50 Hz ratio stimulation. These measurements were taken again during 
the recovery period at:  2, 5, 10, 15, and 20 minutes after the fatigue protocol.    
Supplementation 
  ON™ HMB is a commercially available nutritional supplement for adult use only. 
Participants consumed one tablet three times per day (morning, mid-day, and evening) 
containing a total of 3000 mg of calcium β-Hydroxy-β-Methylbutyrate 
Statistical Analysis 
 Mean differences between groups were examined by using a repeated measures 
ANOVA and the level of significance was set at P < 0.05.  When significant differences 
were observed a post hoc analysis using a Bonferroni correction was used to determine 
where significant differences existed.  All data analyses were completed using SAS 9.3.  
 
 
 
 
 
Copyright © Jordon William Macht 2015 
37 
 
Chapter IV:  Results 
 A total of 33 subjects enrolled in this study (15 Females, 18 males).  Of the 15 
female subjects enrolled, 12 completed all testing procedures and 3 failed to complete 
the post-supplement measures due to lack of compliance.  Of the 18 male subjects 
enrolled, 14 completed all testing procedures and 4 failed to complete the final post-
supplement (96-hours recovery) visit due to temporary testing equipment mechanical 
failure or illness.  Subject characteristics are shown in Table 4.1. 
Table 4.1:  Subject Characteristic Measurements 
 Mean (SD) Range 
   
Age (Years) 23.2 ± 4.3 18 – 34 
 
Height (cm) 173.1 ± 18.3 155.0 – 188.0 
 
Weight (kg) 76.1 ± 15.8 52.9 – 126.5 
 
BMI 25.2 ± 4.1 20.0 – 36.4 
 
Body Fat (%) 22.5 ± 9.5 5.6 – 39.8 
 
 There were significant measurement differences for the MVC torque, 10 Hz Peak 
Torque, 50 Hz Peak Torque, 10/50 Hz Torque Ratio, and TA EMG variable measures.  
The results of these measurement differences are summarized below.  However, there 
were no other variables that showed significant differences between pre-supplement and 
post-supplement measures, or over any of the measurement times. 
10/50 Hz Torque Ratio 
   There was a significant difference in the 10/50 Hz torque ratio over time 
(p<0.0001) and between the pre-supplement limb and the post-supplement limb 
(p=0.005; Table 4.2).  There was no significant difference between limb 10/50 Hz torque 
ratios during the fatigue protocol or the 20-minute recovery period (p=0.16) but, there 
was a significant difference at the 48-hour and 96-hour recovery measurement times 
(p=0.005). 
 The baseline 10/50 Hz torque ratio for the pre-supplement limb was 0.51 ± 0.14 
and for the post-supplement limb it was 0.49 ± 0.11 (Table 4.2).  At the end of the fourth 
set of the fatigue protocol it was reduced to 63% of baseline for the pre-supplement limb 
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(p<0.0001) and 67% of baseline for the post-supplement limb (p<0.0001; Table 4.2).  
Therefore, after the fatigue protocol, both the pre-supplement limb and the post-
supplement limb had a significant relative 10/50 Hz torque ratio deficit.  During the 
recovery period the 10/50 Hz torque ratio continued to decrease at a greater rate in both 
limbs.  At the 20-minute recovery measurement time it was reduced to 49% of baseline 
in the pre-supplement limb (p<0.0001) and 57% of baseline in the post-supplement limb 
(p<0.0001; Table 4.2).  Therefore, after 20 minutes of recovery both the pre-supplement 
limb and the post-supplement limb had a significant relative 10/50 Hz torque ratio deficit.  
  At the 48-hour recovery measurement time, the 10/50 Hz torque ratio in the pre-
supplement limb was 0.40 ± 0.12 and for the post-supplement limb it was 0.47 ± 0.11 
(Table 4.2).  At this measurement time the 10/50 Hz torque ratio, in the pre-supplement 
limb, was reduced to 78% of baseline (p<0.0001) and the post-supplement limb was 
reduced to 96% of baseline (p=0.38; Table 4.2).  Therefore, after 48 hours of recovery, 
the pre-supplement limb had a significant relative 10/50 Hz torque ratio deficit and the 
post-supplement limb had no significant relative 10/50 Hz torque ratio deficits. 
 The 10/50 Hz torque ratio in the pre-supplement limb at the 96-hour recovery 
measurement time was 0.44 ± 0.14 and for the post-supplement limb it was 0.46 ± 0.12 
(Table 4.2).  At this measurement time the 10/50 Hz torque ratio, in the pre-supplement 
limb, was reduced to 86% of baseline (p=0.02) and in the post-supplement limb it was 
94% of baseline (p=0.31; Table 4.2).  Therefore, after 96 hours of recovery, the pre-
supplement limb had a significant relative 10/50 Hz torque ratio deficit and the post-
supplement limb had no significant relative 10/50 Hz torque ratio deficits. 
10 Hz Peak Torque 
 There was a significant difference in 10 Hz peak torque over time (p<0.0001) and 
between the pre-supplement limb and the post-supplement limb (p=0.0008; Table 4.2).  
There was no significant difference between limbs during the fatigue protocol or the 20-
minute recovery period (p=0.89; Table 4.2).  However, there was a significant difference 
at the 48-hour and 96-hour recovery measurement times (p=0.0008; Table 4.2). 
 The baseline 10 Hz peak torque for the pre-supplement limb was 4.8 ± 2.2 Nm 
and for the post-supplement limb it was 4.7 ± 2.4 Nm (Table 4.2).  At the end of the 
fourth set of the fatigue protocol the 10 Hz torque was reduced to 56% of baseline in the 
pre-supplement limb (p<0.0001) and in the post-supplement limb it was reduced to 56% 
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of baseline (p<0.0001; Table 4.2).  Therefore, after the fatigue protocol, both the pre-
supplement limb and the post-supplement limb had a significant relative 10 Hz peak 
torque deficit.  The reduction in the 10 Hz peak torque continued throughout the 
recovery period, and at the 20-minute recovery measurement time it was 47% of 
baseline for the pre-supplement limb (p<0.0001) and 44% of baseline for the post-
supplement limb (p<0.0001; Table 4.2).  Therefore, after 20-minutes of recovery, both 
the pre-supplement limb and the post-supplement limb still had a significant relative 10 
Hz peak torque deficit. 
 The 10 Hz peak torque in the pre-supplement limb at the 48-hour recovery 
measurement time was 3.7 ± 2.1 Nm and for the post-supplement limb it was 4.4 ± 1.9 
Nm (Table 4.2).  At the 48-hour recovery measurement time, in the pre-supplement limb, 
the 10 Hz torque was reduced to 77% of baseline (p<0.0001) and the post-supplement 
limb was reduced to 94% of baseline (p=0.26; Table 4.2).  Therefore, after 48 hours of 
recovery, the pre-supplement limb had a significant relative 10 Hz peak torque deficit 
and the post-supplement limb had no significant relative 10 Hz peak torque deficits. 
 The 10 Hz peak torque in the pre-supplement limb at the 96-hour recovery 
measurement time was 4.2 ± 2.4 Nm and for the post-supplement limb it was 4.3 ± 2.2 
Nm (Table 4.2).  At the 96-hour recovery measurement time the 10 Hz torque in the pre-
supplement limb was reduced to 88% of baseline (p=0.05), and for the post-supplement 
limb it was 94% of baseline (p=0.53; Table 4.2).  In addition, there was a significant 
increase in 10 Hz peak torque from the 48-hour recovery measurement time to the 96-
hour recovery measurement time in the pre-supplement limb (p=0.02;Table 4.2).  
Therefore, after 96 hours of recovery, the pre-supplement limb had a significant relative 
10 Hz peak torque deficit and the post-supplement limb had no significant relative 10 Hz 
peak torque deficits. 
50 Hz Peak Torque 
 There was a significant difference in 50 Hz peak torque over time during the 
fatigue protocol and the 20-minute recovery period (p<0.0001).  But, there was no 
significant difference between baseline and the 48-hour and 96-hour recovery 
measurement times (p=0.19).  Similarly, there was no significant difference in the 50 Hz 
peak torque between the pre-supplement and post-supplement limbs during the fatigue 
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protocol and 20-minute recovery period (p=0.80) or between the 48-hour and 96-hour 
recovery measurement times (p=0.25; Table 4.2).  
 The baseline 50 Hz peak torque for the pre-supplement limb was 10.1 ± 5.5 Nm 
and for the post-supplement limb it was 9.8 ± 5.0 Nm (Table 4.2).  At the end of the 
fourth set of the fatigue protocol the 50 Hz peak torque was reduced to 84% of baseline 
in the pre-supplement limb (p<0.0001) and 80% of baseline in the post-supplement limb 
(p=0.02; Table 4.2).  Therefore, after the fatigue protocol, both the pre-supplement limb 
and the post-supplement limb had a significant relative 50 Hz peak torque deficit.  During 
the recovery period the 50 Hz peak torque continued to increase and at the 20-minute 
recovery measurement time it was recovered to 91% of baseline in the pre-supplement 
limb (p=0.07) and 86% of baseline in the post-supplement limb (p=0.02; Table 4.2).  
Therefore, after 20 minutes of recovery the pre-supplement limb did not show significant 
relative 50 Hz peak torque deficits and the post-supplement limb had a significant 
relative 50 Hz torque deficit.   
 There were no significant differences in the 50 Hz peak torque at the 48-hour 
recovery measurement time or the 96-hour recovery measurement time for either the 
pre-supplement limb (p= 0.18) or the post-supplement limb (p=0.25). 
MVC Torque 
 To test the reliability of the MVC torque measurement an interclass correlation 
coefficient (ICC) and method error was calculated between the familiarization and pre-
supplement testing sessions.  The ICC for MVC torque was 0.999 and the method error 
was 0.51 Nm.  There was a significant difference in MVC torque over time (p<.0001) and 
between the pre-supplement limb and the post-supplement limb (p<.0001; Table 4.2).  
There was no significant difference between limbs during the fatigue protocol or the 20-
minute recovery measurement time (p=.48) however, there was a significant difference 
at the 48-hour and 96-hour recovery measurement times (p<.0001). 
 At baseline the MVC torque for the pre-supplement limb was significantly higher 
when compared to the post-supplement limb (p=0.001).  The MVC torque for the pre-
supplement limb at baseline was 27.6 ± 11.7 Nm and for the post-supplement limb it was 
21.9 ± 8.5 Nm (Table 2).  After the fourth set of the fatigue protocol in the pre-
supplement limb MVC torque was reduced by 13.5 Nm resulting in 51% of the baseline 
measures (p<.0001).  The post-supplement limb was reduced by 10.6 Nm resulting in 
41 
 
52% of baseline measures after the fourth set of the fatigue protocol (p<.0001; Table 
4.2). Therefore, after the fatigue protocol, both the pre-supplement and post-supplement 
limbs had a significant relative MVC torque deficit.  After 20-minutes of recovery 
following the final set of the fatigue protocol, the MVC torque in the pre-supplement limb 
returned to 17.5 ± 1.5 Nm.  At the same measurement time the post-supplement limb 
returned to 15.7 ± 1.6 Nm.  These values were 65% of baseline for the pre-supplement 
limb and 75% of baseline for the post-supplement limb.  The MVC torque for both the 
pre-supplement limb (p<.0001) and post-supplement limb (p=.003) was still significantly 
reduced from baseline following the 20-minute recovery time (Table 4.2).  Therefore, 
after 20-minutes of recovery, both the pre-supplement and post-supplement limbs had a 
significant relative MVC torque deficit. 
 The MVC torque in the pre-supplement limb at the 48-hour recovery 
measurement time was 22.3 ± 9.8 Nm resulting in 81% of the baseline measures 
(p<.0001; Table 4.2).  The MVC torque for the post-supplement limb at this same 
measurement time was 20.5 ± 9.5 Nm resulting in 94% of the baseline measures (p=.53; 
Table 4.2).  Therefore, after 48-hours of recovery, the pre-supplement limb had a 
significant relative MVC torque deficit and the post-supplement limb had no significant 
relative MVC torque deficits. 
 The MVC torque in the pre-supplement limb at the 96-hour recovery 
measurement time was 22.3 ± 10.2 Nm resulting in 81% of the baseline measures 
(p<0.0001; Table 4.2).  The MVC torque for the post-supplement limb at this same 
measurement time was 21.3 ± 9.4 Nm resulting in 97% of the baseline measures 
(p=0.76; Table 4.2). Therefore, after 96 hours of recovery, the pre-supplement limb had 
a significant relative MVC torque deficit and the post-supplement limb had no significant 
relative MVC torque deficits. 
TA EMG 
 There was a significant difference in TA EMG over time (p<.0001) but, there was 
no significant difference between the pre-supplement and post-supplement limbs 
(p=0.08; Table 4.2).  Also, at baseline the TA EMG in the pre-supplement limb was 
significantly higher than the post-supplement limb (p=0.04).   
 The baseline TA EMG for the pre-supplement limb was 161.3 ± 62.9 µV and for 
the post-supplement limb it was 141.1 ± 49.5 µV (Table 4.2).  At the end of the fourth set 
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of the fatigue protocol it was reduced to 64% of baseline for the pre-supplement limb 
(p<0.0001) and 77% of baseline in the post-supplement limb (p<0.0001; Table 4.2).  
Therefore, after the fatigue protocol, both the pre-supplement limb and the post-
supplement limb had a significant relative TA EMG deficit.  During the recovery period 
the TA EMG steadily increased and at the 20-minute recovery measurement time the TA 
EMG was recovered to 71% of baseline in the pre-supplement limb (p=0.0002) and 81% 
of baseline in the post-supplement limb (p=0.003; Table 4.2).  Therefore, after 20 
minutes of recovery, both the pre-supplement limb and the post-supplement limb had a 
significant relative TA EMG deficit.   
   The TA EMG in the pre-supplement limb at the 48-hour recovery measurement 
time was 139.8 ± 64.1 µV and for the post-supplement limb it was 134.5 ± 41.9 µV 
(Table 4.2).  At the 48-hour recovery measurement time the TA EMG was reduced to 
86% of baseline (p=0.01) in the pre-supplement limb and 96% of baseline in the post-
supplement limb (p=0.064; Table 4.2).  Therefore, after 48 hours of recovery, the pre-
supplement limb had a significant relative TA EMG deficit and the post-supplement limb 
had no significant relative TA EMG deficits. 
 The TA EMG in the pre-supplement limb at the 96-hour recovery measurement 
time was 139.3 ± 56.1 µV and for the post-supplement limb it was 135.2 ± 47.3 µV 
(Table 4.2).  At the 96-hour recovery measurement time the TA EMG was reduced to 
86% of baseline (p=0.01) in the pre-supplement limb and 98% of baseline in the post-
supplement limb (p=0.64; Table 4.2).  Therefore, after 96 hours of recovery, the pre-
supplement limb had a significant relative TA EMG deficit and the post-supplement limb 
had no significant relative TA EMG deficits. 
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  Table 4.2:  Pre-Supplement and Post-Supplement Measures for Fatigue Protocol and Recovery Period 
 Baseline Eccentric 
Fatigue Set 1 
Eccentric 
Fatigue Set 2 
Eccentric 
Fatigue Set 3 
Eccentric 
Fatigue Set 4 
 MVC Torque (Nm)     
Pre-Supplement 
Post-Supplement 
27.6 ± 11.7 
21.9 ±  8.5 
23.8 ± 12.4 
17.4 ± 7.5† 
19.1 ± 11.9† 
14.7 ± 8.2† 
16.2 ± 9.9** 
13.4 ± 7.3† 
14.0 ± 9.1† 
11.3 ± 6.8† 
10 Hz Peak Torque (Nm) 
Pre-Supplement 
Post-Supplement 
4.8 ± 2.2 
4.7 ± 2.4 
4.7 ± 2.3 
4.6 ± 2.5 
3.7 ± 2.2† 
3.6 ± 2.4† 
3.2 ± 2.0† 
3.1 ± 2.2† 
2.7 ± 1.9† 
2.6 ± 1.8† 
50 Hz Peak Torque (Nm) 
Pre-Supplement 
Post-Supplement 
10.1 ± 5.5 
9.8 ± 5.0 
9.6 ± 4.8* 
9.0 ± 4.4* 
9.0 ± 4.5† 
8.7 ± 4.7* 
8.5 ± 4.5† 
8.2 ± 4.5† 
8.5 ± 4.6† 
7.8 ± 4.4† 
10/50 Hz Torque Ratio 
Pre-Supplement 
Post-Supplement 
0.51 ± 0.14 
0.49 ± 0.11 
0.52 ± 0.16 
0.51 ± 0.12 
0.42 ± 0.16* 
0.41 ± 0.13† 
0.39 ± 0.16† 
0.37 ± 0.14† 
0.32 ± 0.15† 
0.33 ± 0.12† 
TA EMG (µ Volts) 
Pre-Supplement 
Post-Supplement 
161.3 ± 62.9 
141.1 ± 49.5 
139.2 ± 67.6* 
119.9 ± 46.3* 
128.6 ± 62.2† 
114.2 ± 43.8* 
110.5 ± 41.6† 
114.2 ± 43.8* 
102.4 ± 42.2† 
109.2 ± 47.1† 
  Numbers represent Mean ± Standard Deviation   MVC:  Maximal Voluntary Contraction  
  TA EMG:  Tibialis Anterior Electromyography * p<0.05 Compared to Baseline, † p<0.0001 Compared to Baseline 
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 Table 4.2 (Continued):  Pre-Supplement and Post-Supplement Measures for Fatigue Protocol and Recovery Period 
 
Recovery 2 min 
Recovery 5 
min 
Recovery 10 
min 
Recovery 15 
min 
Recovery 20 
min 
48 Hour 
Recovery 
96 Hour 
Recovery 
MVC Torque (Nm) 
Pre-Supplement 
Post-Supplement 
15.6 ± 9.5† 
14.0 ± 9.5† 
17.4 ± 10.3† 
15.3 ± 9.5* 
17.8 ± 9.1† 
15.8 ± 8.5* 
17.8 ± 9.3† 
15.3 ± 7.8* 
17.9 ± 7.7† 
16.4 ± 7.8* 
22.3 ± 9.8† 
20.5 ± 9.5 
22.3 ± 10.2† 
21.3 ± 9.4 
10 Hz Peak Torque 
(Nm) 
Pre-Supplement 
Post-Supplement 
2.8 ± 1.8† 
2.5 ± 1.7† 
2.5 ± 1.8† 
2.4 ± 1.7† 
2.2 ± 1.4† 
2.1 ± 1.3† 
2.2 ± 1.5† 
2.2 ± 1.3† 
2.3 ± 1.5† 
2.2 ± 1.2† 
3.7 ± 2.1† 
4.4 ± 1.9 
4.2 ±2.4* 
4.3 ± 2.2 
50 Hz Peak Torque 
(Nm) 
Pre-Supplement 
Post-Supplement 
8.9 ± 4.9* 
8.1 ± 4.9* 
8.6 ± 5.2* 
8.1 ± 4.9* 
8.9 ± 5.2* 
8.2 ± 5.1* 
9.1 ± 5.0* 
8.3 ± 5.0* 
9.2 ± 5.0* 
8.4 ± 4.7* 
9.4 ± 4.7 
9.7 ± 4.6 
9.9 ± 5.3 
9.8 ± 4.9 
10/50 Hz Torque 
Ratio 
Pre-Supplement 
Post-Supplement 
0.33 ± 0.15† 
0.32 ± 0.12† 
0.29 ± 0.12† 
0.30 ± 0.12† 
0.27 ± 0.11† 
0.28 ± 0.12† 
0.25 ± 0.11† 
0.28 ± 0.11† 
0.25 ± 0.11† 
0.28 ± 0.12† 
0.40 ± 0.12† 
0.47 ± 0.11 
0.44 ± 0.14* 
0.46 ± 0.12 
TA EMG (µ Volts) 
Pre-Supplement 
Post-Supplement 
99.0 ± 49.3† 
99.0 ± 39.7† 
107.6 ± 53.9† 
105.1 ± 41.0† 
111.1 ± 51.7† 
107.3 ± 40.0† 
112.5 ± 57.8† 
111.9 ± 44.8* 
115.2 ± 52.0* 
114.2 ± 45.4* 
139.8 ± 64.1* 
134.5 ± 41.9 
139.3 ± 56.1* 
135.2 ± 47.3 
 Numbers represent Mean ± Standard Deviation   MVC:  Maximal Voluntary Contraction  
 TA EMG:  Tibialis Anterior Electromyography * p<0.05 Compared to Baseline,   † p<0.0001 Compared to Baseline 
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Figure 4.1:  MVC Torque Measurements for Pre and Post-Supplement Limbs 
 
* p<.05 Compared to baseline  + p<.0001 Compared to baseline 
 
 
Figure 4.2:  10 Hz Peak Torque Measurements for Pre and Post-Supplement Limbs 
 
 
* p<.05 Compared to baseline  + p<.0001 Compared to baseline 
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Figure 4.3:  50 Hz Peak Torque Measurements for Pre and Post-Supplement Limbs 
 
 
* p<.05 Compared to baseline  + p<.0001 Compared to baseline 
 
 
Figure 4.4:  10/50 Hz Torque Ratio for Pre and Post-Supplement Limbs 
 
 
* p<.05 Compared to baseline  + p<.0001 Compared to baseline 
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Figure 4.5:  TA EMG for Pre and Post-Supplement Limbs 
 
 
* p<.05 Compared to baseline  + p<.0001 Compared to baseline 
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Chapter V:  Discussion 
 
 The primary purpose of this study was to determine if three weeks of HMB 
supplementation could attenuate the effects of LFF caused by eccentric muscle 
contractions of the TA muscle.  The major finding of this study was that HMB did 
attenuate the effects of LFF caused by eccentric muscle contractions in the TA muscle.  
This positive finding was due to the results that demonstrated that the 10/50 Hz torque 
ratio, and 10 Hz peak torque in the HMB post-supplement limb recovered faster when 
compared to the pre-supplement limb.  In addition, it was observed that the MVC torque 
in the post-supplement limb recovered faster when compared to the pre-supplement 
limb.  
 The 10/50 Hz torque ratio is a measure of LFF, and any significant reduction in 
the 10/50 Hz torque ratio following completion of a fatigue protocol, is interpreted as LFF 
(60).  After the fatigue protocol, both the pre-supplement limb and the post-supplement 
limb had a significant relative 10/50 Hz torque ratio deficit (Figure 4.4).  This reduction in 
the 10/50 Hz torque ratio indicated that the fatigue protocol used in this study, produced 
significant LFF.  Also, the amount of change in the 10/50 Hz torque ratio that was 
observed in this study for the pre-supplement limb was similar to that found by Power et 
al. (60).  
 The 10/50 Hz torque ratio for the post-supplement limb recovered faster when 
compared to the pre-supplement limb (Figure 4.4).  The post-supplement limb was 
recovered at the 48-hour recovery measurement time and the pre-supplement limb had 
not recovered at the 96-hour recovery measurement time.  The current study supports 
the findings of Jones and colleagues (1989) which reported a torque ratio reduction for 
four days after an eccentric fatigue protocol (22).  Jones et al. (1989) also reported that 
the torque ratio did not return to baseline levels until seven days after the eccentric 
fatigue protocol and that isometric and concentric contractions did not produce a 
reduced torque ratio (22).  Power et al. (2010) reported a depressed torque ratio was 
present immediately after an eccentric fatigue protocol and was still present after 30 
minutes of recovery (60).  Since eccentric contractions have been reported to cause LFF 
and is slow to recover, it is possible that this is a consequence of some form of damage 
caused by the generation of high forces within the muscle (22).  Based on the 10/50 Hz 
torque ratio, the pre-supplement limb was still showing significant LFF at the 96-hour 
recovery measurement time.  In contrast, the post-supplement limb recovered faster, 
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and at the 48-hour recovery measurement time it was no longer showing significant 
signs of LFF.  This is evidence that HMB supplementation positively affected the time 
course of LFF after the fatigue protocol.  This positive affect from HMB supplementation 
may have been the result of reduced muscle damage in the post-supplement limb during 
the fatigue protocol or an increased recovery rate following the fatigue protocol.  Since 
the current study did not employ any direct measure of muscle damage, it cannot be 
concluded which possible mechanism of action of HMB supplementation, may have 
occurred. 
 It has been suggested that HMB supplementation prevents muscle damage or 
regenerates damaged muscle cell membranes after activity (26, 43, 46, 53, 66, 88).  The 
current study may be evidence that supports HMB’s ability to regenerate damaged 
muscle cell membranes.  This is based on the faster recovery of the 10/50 Hz torque 
ratio and 10 Hz peak torque that was seen in the post-supplement limb in the current 
study.  This faster regeneration of damaged muscle cell membranes has been 
suggested to be achieved by two mechanisms (26, 40, 50).  The first mechanism 
involves conversion of HMB, in the cytosol of the liver, to β-hydroxy-β-methylglutarate-
CoA (HMG-CoA) (26, 40, 50).  HMG-CoA is then employed in cholesterol synthesis and 
could be rate limiting when cholesterol synthesis is in high demand, such as during 
periods of rapid cell growth or membrane repair that is seen after eccentric exercise 
(17).  In addition, stressed or damaged muscle cells may not be able to make sufficient 
HMG-CoA to support adequate cholesterol synthesis for cell functions (41).  
Supplemental HMB therefore, may be a source of HMG-CoA in damaged muscle cells to 
maintain adequate cholesterol synthesis and plasma membrane function (41).  The 
second suggested mechanism contributing to the positive effects of HMB 
supplementation concerns HMB’s ability to be polymerized and covalently bonded with 
cell membrane structures to enhance membrane integrity (49, 50).  This increased 
integrity may also be accomplished through the additional source of cholesterol provided 
by HMB supplementation (46).  It has been hypothesized that the de novo synthesized 
cholesterol is used to support the cell membrane integrity, and thus assist in the 
prevention of muscle damage or used to regenerate damaged muscle cell membranes 
(26).  Therefore, HMB supplementation may provide the necessary amount of HMG-CoA 
for cholesterol synthesis and membrane protection that would then result in decreased 
muscle damage and quicker recovery from resistance exercise (17).  This is supported 
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by studies that have demonstrated that HMB supplementation has decreased markers of 
muscle damage following strenuous exercise (17, 26, 40, 55).    
 The 10 Hz peak torque represents low frequency muscle stimulation and in the 
current study it was used as another indicator of LFF.  After the fatigue protocol, and 
following the 20-minute recovery period, both the pre-supplement limb and the post-
supplement limb had a significant relative 10 Hz peak torque deficit (Figure 4.2).  This 
supports the notion that LFF does not have a metabolic or ionic component.  If a 
metabolic or ionic waste product accumulation contributed to the LFF, an increase in the 
10 Hz peak torque toward baseline would be expected during the recovery period as 
seen in high frequency stimulation (i.e. 50 Hz)  (32). 
 In the current study, based on the peak 10 Hz torque, there was still significant 
LFF observed in the pre-supplement limb 96 hours after the fatigue protocol (Figure 4.2).  
In contrast, the 10 Hz peak torque was recovered to non-significant levels in the post-
supplement limb at 48 hours after the fatigue protocol.  This is more evidence that HMB 
supplementation reduced the recovery time of LFF in the current study.  This is because 
the recovery of the post-supplement limb at the 48-hour recovery measurement time is 
in contrast to the pre-supplement limb and other findings reported (22).  Jones et al. 
(1989) reported that low frequency torque was reduced for the first four days after 
eccentric exercise, and did not recover until seven days after eccentric exercise (22). 
 The primary characteristic of LFF is the reduction of muscle force at low 
frequency stimulation (25).  Motor unit discharge rates during voluntary skeletal muscle 
activation rarely exceed 30 Hz, so any voluntary muscle contraction would be greatly 
affected by LFF (25).  This would include any strenuous activity, walking, stair climbing, 
and all other activities of daily living (25).  This effect of LFF on voluntary muscle 
contraction could result in higher activation of the central nervous system, require the 
recruitment of a larger number of motor units or increased firing frequency, and cause 
greater feelings of effort during repetitive activities and may limit performance (25).  The 
current study found that three weeks of HMB supplementation significantly reduced the 
slow recovery of LFF.   
 The 50 Hz peak torque represents high frequency muscle stimulation and in this 
study it was used as an indicator of high frequency fatigue.  At the end of the fatigue 
protocol, both the pre-supplement limb and the post-supplement limb had a significant 
relative 50 Hz peak torque deficit (Figure 4.3).  During the 20-minute recovery period the 
50 Hz peak torque increased in both limbs.  This recovery in the 50 Hz peak torque 
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indicated that high frequency fatigue recovered quickly and suggests that it has a 
metabolic or ionic basis.  It has been previously reported  that, the buildup of metabolic 
byproducts or ions from a fatigue protocol return toward resting levels during the early 
stages of the recovery period  (32).  As these byproducts are restored toward resting 
levels, the 50 Hz peak torque returns toward baseline levels (32).  By the 48-hour 
recovery measurement time the 50 Hz peak torque had recovered to non-significant 
levels in both limbs.  This is evidence that high frequency fatigue recovers faster than 
LFF.  There were no differences between the pre-supplement and post-supplement 
limbs in the 50 Hz peak torque measurement during the fatigue protocol, or any recovery 
measurement times.  Therefore, based on the 50 Hz peak torque measurement it is 
concluded that HMB supplementation had no effect on high frequency fatigue in the 
current study.   
 After the fatigue protocol the MVC torque was reduced by 50% in both the pre-
supplement and the post-supplement limbs and both the pre-supplement and post-
supplement limbs had a significant relative MVC torque deficit (Figure 4.1).  This amount 
of reduction of force demonstrates that the fatigue protocol used in this study was 
intense enough to produce a sufficient amount of muscle fatigue.  This study utilized a 
fatigue protocol adopted from Power et al. (2010) and achieved a greater degree of MVC 
torque reduction (60).  The subjects in the Power et al. study had a MVC torque 
reduction to 72% of baseline after their fatigue protocol (60). 
 At the 20-minute recovery measurement time both the pre-supplement and post-
supplement limbs had a significant relative MVC torque deficit (Figure 4.1).  Due to the 
short time period of this fatigue, it is theorized that the cause of this fatigue is the buildup 
of some metabolite during the fatigue protocol.  It has been reported that the 
concentration of inorganic phosphate (Pi) increases in the muscle fiber during muscle 
contractions (2).  An increase in Pi in the muscle fiber reduces Ca2+ release and 
therefore reduces cross bridge cycling and force production (2).  This type of fatigue can 
also be caused by a reduction in Ca2+ sensitivity (32).  Reduced Ca2+ sensitivity is a 
condition where force at a given free Ca2+ concentration is lowered and it would take 
more Ca2+ release for the same amount of force production. (32).  The accumulation of 
Pi is also thought to reduce Ca2+ sensitivity in a fatiguing muscle (2).  Since both the pre-
supplement and post-supplement limbs were still significantly different from baseline, 
after 20 minutes of recovery, it is concluded that HMB supplementation had no effect on 
short term fatigue.  
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 Muscle damage caused by eccentric muscle contractions has been documented 
directly by muscle biopsy samples and indirectly from losses in strength and range of 
motion, increases in muscle soreness, and increases in blood muscle proteins, such as 
creatine kinase (CK) and lactate dehydrogenase (LDH) (63).  Among these markers, 
change in force generating capacity is considered to be the most reliable (30).  The MVC 
torque in the post-supplement limb also recovered faster than the pre-supplement limb 
at the 48-hour and 96-hour recovery measurement times (Figure 4.1).  This is an 
indicator that a degree of muscle damage was still present in the pre-supplement limb at 
the 96-hour recovery measurement time.  Since the post-supplement limb’s MVC torque 
was nearly fully recovered after 48-hours of recovery, this study suggests that there was 
a positive effect of HMB supplementation on muscle damage recovery time after the 
fatigue protocol.  Since both limbs were reduced to 50% of baseline after the fatigue 
protocol, it is thought that HMB supplementation decreased the recovery time of muscle 
damage, rather than influenced the amount of muscle damage that occurred in the post-
supplement limb.  An explanation of this reduced recovery time could be that HMB 
supplementation increased the repair or resynthesis process of the damaged proteins or 
structures that occurred in the eccentric fatigue protocol. 
 The current study showed that the MVC torque in the post-supplement limb 
recovered faster when compared to the pre-supplement limb.  This could be explained 
by a positive effect of HMB supplementation but, it could also be a result of the baseline 
MVC torque being significantly different between the two limbs.  At baseline the MVC 
torque for the post-supplement limb was 5.7 Nm less than the pre-supplement limb.  
Since the post-supplement limb’s baseline MVC torque was lower, it may have been 
easier and therefore faster for MVC torque to return to non-significant levels after the 
fatigue protocol.  This may have contributed to the post-supplement limb’s faster 
recovery in the current study.    
 After the fatigue protocol, both the pre-supplement limb and the post-supplement 
limb had a significant relative TA EMG deficit which was still present after 20 minutes of 
recovery (Figure 4.5).  This decrease in TA EMG may have been due to central fatigue, 
high frequency peripheral fatigue, or a combination of both factors.  The post-
supplement limb showed no relative TA EMG deficits at the 48-hour recovery 
measurement time and the pre-supplement limb still had relative deficits at the 48-hour 
and 96-hour recovery measurement times.  This is evidence that HMB supplementation 
positively affected the recovery of the TA EMG in the current study.  The current study is 
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in agreement with another study that saw a decrease in EMG activity in the forearm 
flexors after an eccentric fatigue protocol (89).  In addition, it has been reported that 
EMG amplitude declines during maximal isometric contractions (23).  This decline could 
be due to decreases in motor unit firing rates, neuromuscular propagation failure, or the 
slowing of conduction velocity (23).  The current study is not in agreement with two other 
studies that saw increases in EMG activity in the hamstring muscle group (33) and the 
biceps brachii after an eccentric fatigue protocol (67).  It was suggested that the 
increased EMG activity was due to greater recruitment of motor units and an increased 
motor unit discharge rate (67).  The current study did not see an increase in EMG 
activity of the TA muscle after the fatigue protocol.  This may be due to the increased 
central fatigue experienced by the subjects. 
 In conclusion the current study demonstrated that three weeks of HMB 
supplementation reduced the effects and time course of LFF after an eccentric fatigue 
protocol in the TA muscle.  The 10/50 Hz torque ratio and the 10 Hz peak torque 
recovered faster in the post-supplement limb when compared to the pre-supplement 
limb.  In addition, the MVC torque in the post-supplement limb may have recovered 
faster when compared to the pre-supplement limb.  This study also supports the 
literature that there are two components of fatigue after an exercise bout, LFF that has a 
long time course lasting longer than 96 hours and a fast recovering high frequency 
fatigue.  Since HMB supplementation has been shown to reduce LFF caused by 
eccentric muscle contractions it may provide quicker recovery from physical activity for 
recreational athletes, the general public, and people suffering from long term illnesses. 
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Chapter VI:  Summary 
 
Introduction 
 Muscular fatigue, defined as a failure to maintain a required or expected 
force/power for a given task, is a common result of physical activities ranging from 
athletic performance to activities of daily living (31).  Low frequency fatigue (LFF) is 
muscular fatigue that occurs between  5 and  30 Hz stimulation frequency (34).  The 
characteristics of LFF include decreased muscle force that is most severe at low 
stimulation frequencies, slow recovery of force that may take hours or days to resolve, 
and the presence of force decrements may remain in the absence of gross metabolic or 
electrical disturbance of the muscle (2, 3, 25, 34). This form of fatigue may be present 
following any form of intense exercise and is a large contributor to the feeling of muscle 
weakness after exercise (25, 84). The primary characteristic of LFF is the reduction of 
muscle force at low stimulation frequency and this reduction of force is typically greater 
than 50% of rested (baseline) values (25).  Motor unit discharge rates during voluntary 
skeletal muscle activation rarely exceed 30 Hz, therefore, most voluntary muscle 
contractions may be substantially affected by LFF including any strenuous activity, 
walking, stair climbing, and all other activities of daily living (25).   
  It has been previously demonstrated that one of the causes of LFF is a reduction 
in the amount of calcium (Ca2+) released from the sarcoplasmic reticulum (SR) (2).  A 
decrease in Ca2+ release affects muscle tension at low frequencies of stimulation to a 
much greater extent than muscle tension at high frequencies (25, 84).  It seems likely 
that there is some degree of structural damage to one or more of the proteins or 
structures involved in excitation contraction coupling (E-C coupling) and the long time 
course of LFF represents repair or re-synthesis of these proteins or structures (25, 84).  
In support of this muscle damage explanation it has been shown that LFF frequently 
occurs following eccentric exercises, and this LFF remains during the repair process if 
the muscle fiber was damaged during the eccentric exercise (25). 
 Eccentric muscle contractions produce more muscle damage than concentric or 
static contractions (2, 6, 61).  These types of contractions are part of activities of daily 
living including walking downstairs or lowering a heavy weight.  It is believed that the 
greater muscle damage caused by eccentric contractions is due to mechanical insult and 
not metabolic fatigue (6).  In overstretched sarcomeres the sarcoplasmic reticulum could 
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be damaged or its connection with the transverse tubules (T-tubules) might be altered 
(2) .  Potential evidance for this is the reduction in force at low stimulation frequency 
following eccentric muscle contractions (6).  This LFF has been found to be caused by 
E-C uncoupling and in particular a reduced amount of Ca2+ release from the SR (2, 6, 
61, 83). 
 Supporters of a nutritional supplement, β-Hydroxy-β-Methylbutyrate (HMB) 
supplementation, claim that HMB supplementation prevents muscle damage or 
enhances the regeneration of damaged muscle cell membranes.  However, no research 
has evaluated the effect of HMB supplementation on low frequency fatigue. Therefore, 
the purpose of this study was to determine if three weeks of HMB supplementation could 
attenuate the effects of low frequency fatigue caused by eccentric muscle contractions of 
the tibialis anterior muscle.  It was hypothesized that HMB supplementation would 
reduce LFF and enhance recovery after an eccentric exercise protocol.  Therefore, this 
study investigated the effects of three weeks of HMB supplementation on neuromuscular 
performance, following fatiguing exercise, in healthy subjects. 
Research Questions and Hypotheses 
 The first research question that this study sought to answer was:  Are there 
different types of muscle fatigue after an eccentric fatigue protocol in the TA muscle?  It 
was hypothesized that there would be two distinct types of fatigue after the eccentric 
fatigue protocol.  This will include a high frequency fatigue, measured by the 50 Hz peak 
torque which will recover faster than the low frequency fatigue, measured by the 10 Hz 
peak torque.  This hypothesis was based on prior research that showed that there were  
two groups of fatigue after activity and they were low frequency fatigue (LFF) at 5 to 30 
Hz and high frequency fatigue at 50 to 100 Hz (35).  In addition, high frequency fatigue 
recovers very quickly usually within minutes after stimulation or exercise has stopped 
and LFF where recovery of force is slow, taking hours or days (35). 
 The second research question that this study sought to answer was:  Does HMB 
supplementation have any effect on the recovery time of LFF following eccentric 
exercise?  It was hypothesized that HMB supplementation would reduce the recovery 
time of low frequency fatigue following eccentric exercise.  The 10/50 Hz torque ratio 
and 10 Hz peak torque would recover toward baseline levels faster in the HMB 
supplemented limb.  This hypothesis was based on prior research that reported that 
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HMB supplementation prevents muscle damage and/or aids in regenerating damaged 
muscle cell membranes (26, 43, 46, 53, 66, 88). 
 The final research question that this study sought to answer was:  Does HMB 
supplementation have any effect on the recovery time of muscle damage caused by 
eccentric exercise?  It was hypothesized that HMB supplementation would reduce the 
recovery time of muscle damage caused by eccentric exercise.  As demonstrated by a 
faster return of MVC torque to baseline in the HMB supplemented limb.  This hypothesis 
was based on prior research that reported that HMB supplementation imparted 
anticatabolic properties and reduced muscle damage based on reduced enzyme 
markers of muscle damage such as creatine phosphokinase (CK), lactate 
dehydrogenase (LDH), and 3-methylhistidine (3-MH) (17, 21, 55, 70).  In addition, HMB 
was reported to be converted into β-hydroxy-β-methylglutarate-CoA (HMG-CoA) and 
employed in cholesterol synthesis (26, 40, 50).  Without cholesterol, cells cannot 
experience normal growth or recovery (90).  Supplemental HMB therefore, may be a 
source of HMG-CoA in damaged muscle cells to maintain adequate cholesterol 
synthesis and allow for maximal cell growth, function, and recovery (41, 71).   
Discussion 
  The major finding of this study was that HMB did attenuate the effects of LFF 
caused by eccentric muscle contractions in the TA muscle.  This positive finding was 
supported by the results that demonstrated that the 10/50 Hz torque ratio, and 10 Hz 
peak torque in the HMB post-supplement limb recovered faster when compared to the 
pre-supplement limb.  In addition, it was observed that the MVC torque in the post-
supplement limb recovered faster when compared to the pre-supplement limb.  The 
current study may be evidence that supports HMB’s ability to regenerate damaged 
muscle cell membranes.  This is based on the faster recovery of the 10/50 Hz torque 
ratio, 10 Hz peak torque and MVC torque that was seen in the post-supplement limb in 
the current study. 
 The 10/50 Hz torque ratio is a measure of LFF, and any significant reduction in 
the 10/50 Hz torque ratio following completion of a fatigue protocol, is interpreted as LFF 
(60).  The 10/50 Hz torque ratio for the post-supplement limb recovered faster when 
compared to the pre-supplement limb (Figure 4.4).  The post-supplement limb was 
recovered at the 48-hour recovery measurement time and the pre-supplement limb was 
not recovered at the 96-hour recovery measurement time.  Based on the 10/50 Hz 
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torque ratio, the pre-supplement limb was still showing significant LFF at the 96-hour 
recovery measurement time.  In contrast, the post-supplement limb recovered faster, 
and at the 48-hour recovery measurement time it was no longer showing significant 
signs of LFF.  This is evidence that HMB supplementation positively affected the time 
course of LFF after the fatigue protocol.   
 The 10 Hz peak torque represents low frequency muscle stimulation and in the 
current study it was used as another indicator of LFF.  After the fatigue protocol, and 
following the 20-minute recovery period, both the pre-supplement limb and the post-
supplement limb had a significant relative 10 Hz peak torque deficit (Figure 4.2).  In the 
current study, based on the peak 10 Hz torque, there was still significant LFF observed 
in the pre-supplement limb 96 hours after the fatigue protocol (Figure 4.2).  In contrast, 
the 10 Hz peak torque was recovered to non-significant levels in the post-supplement 
limb at 48 hours after the fatigue protocol.  This is more evidence that HMB 
supplementation reduced the recovery time of LFF in the current study.   
 Based on these findings HMB supplementation may be beneficial to athletes, 
recreational athletes, elderly, and anyone who participates in physical activity.  This 
supplement would be most beneficial to people who experience high levels of muscle 
damage and LFF during physical activity.  This would include sedentary people starting 
a physical activity program or active people changing their physical activity program.  In 
these cases the potential for muscle damage and LFF is high and HMB supplementation 
may help these individuals recover more quickly from physical activity.  This supplement 
would not be beneficial to individuals who are active and not changing their programs.  
This is because the potential for muscle damage and LFF would be low and HMB 
supplementation would not help these individuals recover from physical activity faster.    
 The 50 Hz peak torque represents high frequency muscle stimulation and in this 
study it was used as an indicator of high frequency fatigue.  At the end of the fatigue 
protocol, both the pre-supplement limb and the post-supplement limb had a significant 
relative 50 Hz peak torque deficit (Figure 4.3).  During the 20-minute recovery period the 
50 Hz peak torque increased in both limbs.  By the 48-hour recovery measurement time 
the 50 Hz peak torque had recovered to non-significant levels in both limbs.  This is 
evidence that high frequency fatigue recovers faster than LFF.  There were no 
differences between the pre-supplement and post-supplement limbs in the 50 Hz peak 
torque measurement during the fatigue protocol, or any recovery measurement times.  
Therefore, based on the 50 Hz peak torque measurement it is concluded that HMB 
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supplementation had no effect on high frequency fatigue in the current study.   At the 20-
minute recovery measurement time both the pre-supplement and post-supplement limbs 
had a significant relative MVC torque deficit (Figure 4.1).  Since both the pre-supplement 
and post-supplement limbs were still significantly different from baseline, after 20 
minutes of recovery, it is concluded that HMB supplementation had no effect on short 
term muscle fatigue.  Future research should focus on nutritional supplements that 
enhance performance and reduce the amount of force loss during a fatiguing protocol.  If 
such a supplement can be found then high frequency fatigue and force loss would be 
reduced during physical activity and performance would increase. 
 The MVC torque in the post-supplement limb also recovered faster than the pre-
supplement limb at the 48-hour and 96-hour recovery measurement times (Figure 4.1).  
This is an indicator that a degree of muscle damage was still present in the pre-
supplement limb at the 96-hour recovery measurement time.  Since the post-supplement 
limb’s MVC torque was nearly fully recovered after 48-hours of recovery, this study 
suggests that there was a positive effect of HMB supplementation on muscle damage 
during the recovery time after the fatigue protocol.  An explanation of this reduced 
recovery time could be that HMB supplementation increased the repair or resynthesis 
process of the damaged proteins or structures that occurred during the eccentric fatigue 
protocol.  This is more support that HMB supplementation may be beneficial to 
individuals who experience high levels of muscle damage during their physical activity. 
  The current study showed that the MVC torque in the post-supplement limb 
recovered faster when compared to the pre-supplement limb.  This could be explained 
by a positive effect of HMB supplementation but, it could also be a result of the baseline 
MVC torque being significantly different between the two limbs.  At baseline the MVC 
torque for the post-supplement limb was 5.7 Nm less than the pre-supplement limb.  
Since the post-supplement limb’s baseline MVC torque was lower, it may have been 
easier for it to return to non-significant levels after the fatigue protocol.  This may have 
contributed to the post-supplement limb’s faster recovery in the current study.    
 
 Conclusion 
 The current study demonstrated that three weeks of HMB supplementation 
reduced the effects and time course of LFF after an eccentric fatigue protocol in the TA 
muscle.  The 10/50 Hz torque ratio, and the 10 Hz peak torque recovered faster in the 
post-supplement limb when compared to the pre-supplement limb.  In addition, the MVC 
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torque in the post-supplement limb may have recovered faster when compared to the 
pre-supplement limb.  This study also supports the literature that there are two 
components of fatigue after an exercise bout, LFF that has a long time course, lasting 
longer than 96 hours, and  a fast recovering high frequency fatigue.  Since HMB 
supplementation has been shown to reduce LFF caused by eccentric muscle 
contractions it may provide quicker recovery from physical activity for recreational 
athletes, the general public, and people suffering from long term illnesses.   
 
Future Research 
 The TA muscle used in this study is not a highly trained muscle and the subjects 
used were only recreationally active.  So, future research should be focused on HMB’s 
ability to reduce the effects of LFF in other muscles and different populations, such as 
highly trained, non-trained, and older populations.  The quadriceps muscle group would 
be a good muscle for future research in HMB’s ability to positively effect LFF and muscle 
damage.  This is because the quadriceps muscle group is a prime mover in many 
activities and sporting events.  Also, for the elderly population the quadriceps are the 
main muscles in rising from a chair and locomotion.   
 Full training studies with HMB supplementation should be conducted to assess 
its effects on the whole body during an exercise program.  Since the current study 
potentially supports HMB’s ability to increase muscle recovery from muscle damage, the 
training studies should be designed to produce muscle damage.  This could be done by 
using a sedentary population starting a training program or a trained population that 
would be drastically changing their program.  A reason that some training studies did not 
see any benefit of HMB supplementation could be because the training itself did not 
cause significant muscle damage and LFF in the subjects used.  In addition, these 
studies should be of varying lengths to test HMB’s effects on reducing muscle damage 
over different periods of time. 
 The current study supports HMB’s ability to reduce muscle damage but, no direct 
measures of muscle damage were used in this study.  So, future research, involving 
HMB, should utilize some form of direct measure of muscle damage.  This could include 
muscle biopsies or measures of plasma proteins such as creatine phosphokinase, 
lactate dehydrogenase or 3-methylhistidine.  In these types of studies it could be shown 
if HMB supplementation improves protein synthesis or decreases protein breakdown 
after physical activity. 
60 
 
References 
1. ACSM's Guidelines for Exercise Testing and Prescription. 8 ed, ed. W.R. Thompson. 2010, 
Baltimore, MD: Wolters Kluwer. 
2. Allen, D.G., Westerblad, H., Role of phosphate and calcium stores in muscle fatigue. 
Journal of Physiology, 2001. 536(3): p. 657-665. 
3. Balog, E.M., Excitation contraction coupling and minor triadic proteins in low frequency 
fatigue. Exerc Sport Sci Rev, 2010. 38(3): p. 135-142. 
4. Brockett, C.L., Morgan, D. L., and Proske, U., Human hamstring muscles adapt to 
eccentric exercise by changing optimum length. Med Sci Sports Exerc, 2001. 33(5): p. 
783-790. 
5. Clark, R., et al., Nutritional treatment for acquired immunodeficiency virus-associated 
wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a 
randomized, double-blind, placebo-controlled study. Journal of Parenteral and Enteral 
Nutrition, 2000. 24(3): p. 133-139. 
6. Clarkson, P.M., and Hubal, M.J., Exercise-Induced Muscle Damage in Humans. Am J Phys 
Med Rehabil, 2002. 81 (Suppl): p. S52-S69. 
7. Clarkson, P.M. and M.J. Hubal, Exercise-induced muscle damage in humans. Am J Phys 
Med Rehabil, 2002. 81(11 Suppl): p. S52-69. 
8. Clarkson, P.M., Hubal, M.J., Exercise-Induced muscle damage in humans. Am. J. Phys. 
Med. Rehabil., 2002. 81(11): p. S52-S69. 
9. Clarkson, P.M., Nosaka, K., and Braun, B., Muscle function after exercise-induced muscle 
damage and rapid adaptation. Med Sci Sports Exerc, 1992. 24(5): p. 512-520. 
10. Eley, H.L., Russell, S. T., Baxter, J. H., Mukerji, P., and Tisdale, M. J., Signaling pathways 
initiated by β-hydroxy-β-methylbutyrate to attenuate the depression of protein synthesis 
in skeletal muscle in response to cachectic stimuli. Am J Physiol Endocrinol Metab, 2007. 
293: p. E923-E931. 
11. Enoka, R.M.a.D., J., Muscle fatigue:  what, why and how it influences muscle function. J 
Physiol, 2008. 586(1): p. 11-23. 
12. Evans, W.J. and C.P. Lambert, Physiological Basis of Fatigue. American Journal of 
Physical Medicine & Rehabilitation, 2007. 86(Supplement): p. S29-S46. 
13. Fitschen, P.J., G.J. Wilson, J.M. Wilson, and K.R. Wilund, Efficacy of beta-hydroxy-beta-
methylbutyrate supplementation in elderly and clinical populations. Nutrition, 2012. 
14. Fitts, R.H., The cross-bridge cycle and skeletal muscle fatigue. J Appl Physiol, 2028. 104: 
p. 551-558. 
15. Flakoll, P., et al., Effect of beta-hydroxy-beta-methylbutyrate, arginine, and lysine 
supplementation on strength, functionality, body composition, and protein metabolism 
in elderly women. Nutrition, 2004. 20(5): p. 445-51. 
16. Gallagher, P.M., Carrithers, J.A., Godard, M.P., Schulze, K.E., and Trappe, S.W., Beta-
hydroxy-beta-methylbutyrate ingestion, Part I:  effects on strength and fat free mass. 
Med. Sci. Sports Exerc., 2000. 32(12): p. 2109-2115. 
17. Gallagher, P.M., Carrithers, J.A., Godard, M.P., Schulze, K.E., and Trappe, S.W., Beta-
hydroxy-beta-methylbutyrate ingestion, Part I:  Effects on strength and fat free mass. 
Med Sci Sports Exerc, 2000. 32(12): p. 2109-2115. 
18. Gallagher, P.M., Carrithers, J.A., Godard, M.P., Schulze, K.E., and Trappe, S.W., Beta-
hydroxy-beta-methylbutyrate ingestion, part:  II effects on hematology, hepatic and 
renal function. Med Sci Sports Exerc, 2000. 32(12): p. 2116-2119. 
61 
 
19. Garlick, P.J., The Role of Leucine in the Regulation of Protein Metabolism. J Nutr, 2005. 
135: p. 1553S-1556S. 
20. Hoffman, J.R., Cooper, J., Wendell, M., Im, J., and Kang, J., Effects of β-Hydroxy β-
Methylbutyrate on power performance and indices of muscle damage and stress during 
high-intensity training. J Strength Cond Res, 2004. 18(4): p. 747-752. 
21. Hoffman, J.R., Cooper, J., Wendell, M., Im, J., and Kang, J., Effects of β-Hydroxy β-
Methylbutyrate on power performance and indices of muscle damage and stress during 
high-intensity training. J Strength Cond Res, 2004. 18(4): p. 747-752. 
22. Jones, D.A., Newham, D.J., and Torgan, C., Mechanical influences on long-lasting human 
muscle fatigue and delayed-onset pain. J Physiol, 1989. 412: p. 415-427. 
23. Kamen, G. and D.A. Gabriel, Essentials of Electromyography. 2010: Human Kinetics. 
24. Keeton, R.B. and S. Binder-Macleod, Low Frequency Fatigue. Phys Ther, 2006. 86(6): p. 
1146-1150. 
25. Keeton, R.B.a.B.-M., S.A., Low Frequency Fatigue. Phys Ther, 2006. 86(8): p. 1146-1150. 
26. Knitter, A.E., Panton, L., Rathmacher, J.A., Petersen, A., and Sharp R., Effects of β-
Hydroxy β-Methylbutyrate on muscle damage after a prolonged run. J Appl Physiol, 
2000. 89: p. 1340-1344. 
27. Knitter, A.E., Panton, L., Rathmacher, J.A., Petersen, A., and Sharp, R., Effects of β-
Hydroxy β-Methylbutyrate on muscle damage after a prolonged run. J Appl Physiol, 
2000. 89: p. 1340-1344. 
28. Kornasio, R., et al., Beta-hydroxy-beta-methylbutyrate (HMB) stimulates myogenic cell 
proliferation, differentiation and survival via the MAPK/ERK and PI3K/Akt pathways. 
Biochim Biophys Acta, 2009. 1793(5): p. 755-63. 
29. Kreider, R.B., Ferreira, M., Wilson, M., and Almada, A.L., Effects of calcium β-hydroxy-β-
methylbutyrate (HMB) supplementation during resistance training on markers of 
catabolism, body composition and strength. Int J Sport Nut Exer Med, 1999. 20: p. 503-
509. 
30. Lauritzen, F., Paulsen, G., Raastad, T., Bergersen, L. H., and Owe, S. G., Gross 
ultrastructural changes and necrotic fiber segments in elbow flexor muscles after 
maximal voluntary eccentric action in humans. J App Physiol, 2009. 107: p. 1923-1934. 
31. Macintosh, B.R., P.F. Gardiner, and A.J. McComas, Skeletal muscle form and function, 
Second Edition. 2006, P.O. Box 5076, Champaign, IL: Human Kinetics. 
32. MacIntosh, B.R., Gardiner, P.F., and McComas, A.J., Skeletal Muscle Form and Function, 
Second Edition. 2006, P.O. Box 5076, Champaign, IL: Human Kinetics. 
33. Marshall, P.W., R. Lovell, M.F. Knox, S.L. Brennan, and J.C. Siegler, Hamstring fatigue and 
muscle activation changes during six sets of Nordic hamstring exercise in amateur soccer 
players. J Strength Cond Res, 2015. 
34. Matsunaga, T., Shimada, Y., and Sato, K., Muscle fatigue from intermittent stimulation 
with low and high frequency electrical pulses. Arch Phys Med Rehabil, 1999. 80: p. 48-
53. 
35. Matsunaga, T., Shimada, Y., and Sato, K., Muscle fatigue from intermittent stimulation 
with low and high frequency electrical pulses. Arch Phys Med Rehabil, 1999. 80: p. 48-
53. 
36. May, P.E., Barber, A., D'Olimpio, J. T., Hourihane, A., and Abumrad, N. N., Reversal of 
cancer-related wasting using oral supplementation with a combination of β-hydroxy-β-
methylbutyrate, arginine, and glutamine. Am J Surg, 2002. 183: p. 471-479. 
37. Metzger, J.M.a.F., R.H., Fatigue from high and low frequency muscle stimulation 
contractile and biochemical alterations. J Appl Physiol, 1987. 62: p. 2075-2082. 
62 
 
38. Newham, D.J., McPhail, G., Mills, K.R., and Edwards, R.H.T., Ultrastructural changes after 
concentric and eccentric contractions of human muscle. J Neurological Sciences, 1983. 
61: p. 109-122. 
39. Nissen, S., Sharp, R., Ray, M., Rathmacher, J.A., Rice, D., Fuller, J.C., Connelly, A.S., and 
Abumrad, N., Effect of leucine metabolite β-Hydroxy β-Methylbutyrate on muscle 
metabolism during resistance-exercise training. J Appl Physiol, 1996. 81: p. 2095-2104. 
40. Nissen, S., Sharp, R., Ray, M., Rathmacher, J.A., Rice, D., Fuller, J.C., Connelly, A.S., and 
Abumrad, N., Effect of leucine metabolite β-Hydroxy β-Methylbutyrate on muscle 
metabolism during resistance-exercise training. J Appl Physiol, 1996. 81: p. 2095-2104. 
41. Nissen, S., Sharp, R.L., Panton, L., Vukovich, M., Trappe, S., and Fuller, J.C., β-Hydroxy-β-
Methylbutyrate (HMB) Supplementation in Humans Is Safe and May Decrease 
Cardiovascular Risk Factors. J Nutr, 2000. 130: p. 1937-1945. 
42. Nissen, S.L., Abumrad, N.N., Nutritional role of the leucine metabolite β-hydroxy-β-
methylbutyrate (HMB). Nutr. Biochem., 1997. 8: p. 300-311. 
43. Nissen, S.L. and R.L. Sharp, Effect of dietary supplements on lean mass and strength 
gains with resistance exercise: a meta-analysis. J Appl Physiol, 2003. 94(2): p. 651-9. 
44. Norton, L.E. and D.K. Layman, Leucine Regulates Translation Initiation of Protein 
Synthesis in Skeletal Muscle after Exercise. J Nutr, 2006. 136: p. 533S - S537. 
45. Nosaka, K., Newton, M., and Sacco, P., Responses of human elbow flexor muscles to 
electrically stimulated forced lengthening exercise. Acta Physiol Scand, 2002. 174: p. 
137-145. 
46. Nunan, D., Howatson, G., and van Someren, K.A. , Exercise-induced muscle damage is 
not attenuated by β-Hydroxy β-Methylbutyrate and α-Ketoisocaproic acid 
supplementation. J Strength Cond Res, 2010. 24(2): p. 531-537. 
47. Nunes, E.A., et al., Beta-hydroxy-beta-methylbutyrate supplementation reduces tumor 
growth and tumor cell proliferation ex vivo and prevents cachexia in Walker 256 tumor-
bearing rats by modifying nuclear factor-kappaB expression. Nutr Res, 2008. 28(7): p. 
487-93. 
48. O'Connor, D.M., Crowe, M.J., Effects of six weeks of β-Hydroxy β-Methylbutyrate (HMB) 
and HMB-creatine supplementation on strength, power, and anthropometry of highly 
trained athletes. J Strength Cond Res, 2007. 21(2): p. 419-423. 
49. O'Connor, D.M.a.C., M.J., Effects of six weeks of β-Hydroxy β-Methylbutyrate (HMB) and 
HMB/creatine supplementation on strength, power, and anthropometry of highly 
trained athletes. J Strength Cond Res, 2007. 21(2): p. 419-423. 
50. O'Connor, D.M.a.C., M.J., Effects of β-Hydroxy β-Methylbutyrate and creatine 
monohydrate supplementation on the aerobic and anaerobic capacity of highly trained 
athletes. J Sports Med Phys Fitness, 2003. 43: p. 64-68. 
51. Ostaszewski, P., Kostiuk, S. Balasinska, B., Jank, M., Papet, I., and Glomot, F., The leucine 
metabolite 3-hydroxy-3-methylbutyrate (HMB) modifies protein turnover in muscles of 
laboratory rats and domestic chickens in vitro. J Anim. Physiol. Anim. Nutr., 2000. 84: p. 
1-8. 
52. Paddon-Jones, D., Keech, A., and Jenkins, D., Short-term β-Hydroxy β-Methylbutyrate 
supplementation does not reduce symptoms of eccentric muscle damage. Int. J. Sport 
Nut. Exer. Met., 2001. 11: p. 442-450. 
53. Paddon-Jones, D., Keech, A., and Jenkins, D., Short-term β-Hydroxy β-Methylbutyrate 
supplementation does not reduce symptoms of eccentric muscle damage. Int J Sport 
Nutr Exerc Metab, 2001. 11: p. 442-450. 
63 
 
54. Palisin, T.a.S., J.J., β-Hydroxy β-Methylbutyrate and its use in athletics. Curr Sports Med 
Rep, 2005. 4: p. 220-223. 
55. Panton, L.B., Rathmacher, A., Baier, S., and Nissen, S., Nutritional supplementation of 
the leucine metabolite β-Hydroxy β-Methylbutyrate (HMB) during resistance training. 
Nutrition, 2000. 16: p. 734-739. 
56. Panton, L.B., Rathmacher, J.A., Baier, S., and Nissen, S., Nutritional supplementation of 
the leucine metabolite β-Hydroxy β-Methylbutyrate (HMB) during resistance training. 
Nutrition, 2000. 16: p. 734-739. 
57. Pinheiro, C.H., et al., Metabolic and functional effects of beta-hydroxy-beta-
methylbutyrate (HMB) supplementation in skeletal muscle. Eur J Appl Physiol, 2012. 
112(7): p. 2531-7. 
58. Portal, S., et al., The effect of HMB supplementation on body composition, fitness, 
hormonal and inflammatory mediators in elite adolescent volleyball players: a 
prospective randomized, double-blind, placebo-controlled study. Eur J Appl Physiol, 
2011. 111(9): p. 2261-9. 
59. Portal, S., Zadik, Z., Rabinowitz, J., Pilz-Burstein, R., Adler-Portal, D., Meckel, Y., Cooper, 
D. M., Eliakim, A., and Nemet, D., The effect of HMB supplementation on body 
composition, fitness, hormonal and inflammatory mediators in elite adolescent volleyball 
players: a prospective randomized, double-blind, placebo-controlled study. Eur J Appl 
Physiol, 2011. 111(9): p. 2261-9. 
60. Power, G.A., B.H. Dalton, C.L. Rice, and A.A. Vandervoort, Delayed recovery of velocity-
dependent power loss following eccentric actions of the ankle dorsiflexors. J Appl Physiol, 
2010. 109: p. 669-676. 
61. Power, G.A., Dalton, B.H., Rice, C.L., and Vandervoort, A.A., Delayed recovery of velocity-
dependent power loss following eccentric actions of the ankle dorsiflexors. J Appl Physiol, 
2010. 2010(109): p. 669-676. 
62. Ransone, J., Neighbors, K., LeFavi, R., and Chromiak, J., The Effect of beta Hydroxy beta 
Methylbutyrate on muscular strength and body composition in collegiate football 
players. J Strength Cond Res, 2003. 17(1): p. 34-39. 
63. Rinard, J., P.M. Clarkson, L.L. Smith, and M. Grossman, Response of males and females 
to high-force eccentric exercise. J Sports Sci, 2000. 18(4): p. 229-36. 
64. Rinard, J., Clarkson, P. M., Smith, L. L., and Grossman, M., Response of males and 
females to high-force eccentric exercise. J Sports Sci, 2000. 18(4): p. 229-36. 
65. Rowlands, D.S., Thomson, J.S., Effects of β-Hydroxy β-Methylbutyrate supplementation 
during resistance training on strength, body composition, and muscle damage in trained 
and untrained young men:  A meta-analysis. J Sports Med Phys Fit, 2009. 23(3): p. 836-
846. 
66. Rowlands, D.S.a.T., J.S., Effects of β-Hydroxy β-Methylbutyrate supplementation during 
resistance training on strength, body composition, and muscle damage in trained and 
untrained young men  A meta-analysis. J Strength Cond Res, 2009. 23(3): p. 836-846. 
67. Semmler, J.G., Motor unit activity after eccentric exercise and muscle damage in 
humans. Acta Physiol (Oxf), 2014. 210(4): p. 754-67. 
68. Seung, J.C.a.W., J.J., Combined effects of fatigue and eccentric damage on muscle power. 
J Appl Physiol, 2009. 107: p. 1156-1164. 
69. Slater, G., Jenkins, D., Logan, P., Lee, H., Vukovich, M., Rathmacher, J.A. and Hahn, A.G., 
β-Hydroxy β-Methylbutyrate (HMB) Supplementation does not affect changes in 
strength or body composition during resistance training in trained men. Int. J. Sport Nut. 
Exer. Met., 2001. 11: p. 384-396. 
64 
 
70. Slater, G., Jenkins, D., Logan, P., Lee, H., Vukovich, M., Rathmacher, J.A., and Hahn A.G., 
β-Hydroxy β-Methylbutyrate (HMB) Supplementation does not affect changes in 
strength or body composition during resistance training in trained men. Int J Sport Nutr 
Exerc Metab, 2001. 11: p. 384-396. 
71. Slater, G.J. and D. Jenkins, β-Hydroxy β-Methylbutyrate (HMB) supplementation and the 
promotion of muscle growth and strength. Sports Med 2000. 30(2): p. 105-116. 
72. Slater, G.J., Jenkins, D., β-Hydroxy β-Methylbutyrate (HMB) supplementation and the 
promotion of muscle growth and strength. Sports Med, 2000. 30(2): p. 105-116. 
73. Slater, G.J.a.J., D., β-Hydroxy β-Methylbutyrate (HMB) supplementation and the 
promotion of muscle growth and strength. Sports Med, 2000. 30(2): p. 105-116. 
74. Smith, H.J., Mukerji, P., and Tisdale, M.J., Attenuation of Proteasome-Induced Proteolysis 
in Skeletal Muscle by β-Hydroxy-β-Methylbutyrate in Cancer-Induced Muscle Loss. 
Cancer Res, 2005. 65: p. 277-283. 
75. Smith, H.J., S.M. Wyke, and M.J. Tisdale, Mechanism of the attenuation of proteolysis-
inducing factor stimulated protein degradation in muscle by beta-hydroxy-beta-
methylbutyrate. Cancer Res, 2004. 64(23): p. 8731-5. 
76. Thomson, J.S., Watson, P.E., and Rowlands, D.S., Effects of nine weeks of β-Hydroxy β-
Methylbutyrate supplementation on strength and body composition in resistance trained 
men. J Strength Cond Res, 2009. 23(3): p. 827-835. 
77. Thomson, J.S., Watson, P.E., and Rowlands, D.S., Effects of nine weeks of β-Hydroxy β-
Methylbutyrate supplementation on strength and body composition in resistance trained 
men. J Strength Cond Res, 2009. 23(3): p. 827-835. 
78. Van Koevering, M. and S. Nissen, Oxidation of leucine and alpha-ketoisocaproate to 
beta-hydroxy-beta-methylbutyrate in vivo. Am J Physiol Endocrino Metab, 1992. 262: p. 
E27-E31. 
79. Van Someren, K.A., Edwards, A.J., and Howatson, G., Supplementation with β-Hydroxy β-
Methylbutyrate (HMB) and α-Ketoisocaproic acid (KIC) reduces signs and symptoms of 
exercise induced muscle damage in man. Int. J. Sport Nut. Exer. Met., 2005. 15: p. 413-
424. 
80. Van Someren, K.A., Edwards, A.J., and Howatson, G., Supplementation with β-Hydroxy β-
Methylbutyrate (HMB) and α-Ketoisocaproic acid (KIC) reduces signs and symptoms of 
exercise induced muscle damage in man. Int J Sport Nutr Exerc Metab, 2005. 15: p. 413-
424. 
81. Vukovich, M.D., Slater, G., Macchi, M.B., Turner, M.J., Fallon, K., Boston, T., and 
Rathmacher, J., β-hydroxy-β-methylbutyrate (HMB) kinetics and the influence of glucose 
ingestion in humans. J Nutr. Biochem., 2001. 12: p. 631-639. 
82. Vukovich, M.D., Stubbs, N.B., and Bohlken, R.M., Body composition in 70-Year-Old adults 
responds to dietary β-Hydroxy β-Methylbutyrate similarly to that of young adults. J Nutr, 
2001. 131: p. 2049-2052. 
83. Warren, G.L., Ingalls, C.P., Lowe, D.A., and Armstrong, R.B., Excitation-contraction 
uncoupling:  Major role in contraction-induced muscle injury. Exerc Sport Sci Rev, 2001. 
29(2): p. 82-87. 
84. Westerbald, H., Allen, D.G., Bruton, J.D., Andrade, F.H. and Lannergren, J., Mechanisms 
underlying the reduction of isometric force in sleletal muscle fatigue. Acta Physiol Scand, 
1998. 162: p. 253-260. 
85. Westerblad, H., Duty, S., and Allen, D.G., Intracellular calcium concentration during low 
frequency fatigue in isolated single fibers of mouse skeletal muscle. J Appl Physiol, 1993. 
75: p. 382-388. 
65 
 
86. Westerblad, H., Lee, J.A., Lannergren, J. and Allen, D.G., Cellular mechanisms of fatigue 
in skeletal muscle. Am J Phys Cell Physiol, 1991. 261: p. C195-C209. 
87. Wilson, G.J., Wilson, J. M., and Manninen, A. H., Effects of beta-hydroxy-beta-
methylbutyrate (HMB) on exercise performance and body composition across varying 
levels of age, sex, and training experience: A review. Nutr Metab (Lond), 2008. 5: p. 1-17. 
88. Wilson, J.M., et al., Acute and timing effects of beta-hydroxy-beta-methylbutyrate (HMB) 
on indirect markers of skeletal muscle damage. Nutr Metab (Lond), 2009. 6: p. 6. 
89. YE, X., T.W. Beck, J.M. Defreitas, and N.P. Wages, An examination of the strenght and 
electromyographic responses after concentric vs. eccentric exercise of the forearm 
flexors. J Strength Cond Res, 2014. 28(4): p. 1072-1080. 
90. Yeagle, P.L., Modulation of membrane function by cholesterol. Biochimie, 1991. 73: p. 
1303-1310. 
91. Zanchi, N.E., et al., HMB supplementation: Clinical and athletic performance-related 
effects and mechanisms of action. Amino Acids, 2011. 40(4): p. 1015-25. 
92. Zanchi, N.E., Gerlinger-Romero, F., Guimaraes-Ferreira, L., de Siqueira Filho, M. A., 
Felitti, V., Lira, F. S., Seelaender, M., and Lancha, A. H., Jr., HMB supplementation: 
clinical and athletic performance-related effects and mechanisms of action. Amino Acids, 
2011. 40(4): p. 1015-25. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
66 
 
CURRICULUM VITAE 
Jordon W. Macht, M.S., CSCS 
 
Office Address University of Kentucky 
   Department of Kinesiology and Health Promotion 
   100 Seaton Center 
   Lexington, Ky 40506-0219 
   (859) 462-8052 
   jordon.macht@uky.edu 
   jordonmacht@hotmail.com 
 
EDUCATION 
2011-Present  Ph.D. in progress, Exercise Science 
   Department of Kinesiology and Health Promotion 
   University of Kentucky 
   Lexington, Ky 
Dissertation:  β-Hydroxy-β-Methylbutyrate (HMB) Supplementation and its Effects on 
Neuromuscular Properties 
 
2009-2011  M.S., Exercise Physiology 
   Department of Kinesiology and Health Promotion 
   University of Kentucky 
   Lexington, Ky 
Thesis:  Development of 1-Repetition Maximum Prediction Equations for Bench Press in 
Moderately Trained Men 
 
1996-2001  B.A., Physical Education-Recreation/Fitness 
   Northern Kentucky University 
   Department of Kinesiology and Health 
   Highland Heights, Ky 
 
HONORS/AWARDS 
March, 2014  Arvle and Ellen Turner Thacker Graduate Dissertation Research  
   Fund 
   Awarded:  $1,000 
 
2009-2014  Graduate Assistantship 
   Health and Wellness Department 
   University of Kentucky 
 
2003   National Strength and Conditioning Association (NSCA) 
   Passed Certified Strength and Conditioning Specialist (CSCS)  
   exam 
 
 
67 
 
TEACHING EXPERIENCE 
 
2014-Present  Lead Instructor, Lexington Healing Arts Academy 
   Subjects taught:  Anatomy and Physiology, Kinesiology, Exercise  
   Physiology   
   Lexington, KY 
 
2009-Present  Time to Change Program 
   Department of Campus Recreation 
   University of Kentucky 
   Lexington, KY 
 
 
2013   Teaching Assistant, KHP 640 Laboratory Methods in Exercise  
   Science 
   Department of Kinesiology and Health Promotion 
   University of Kentucky 
   Lexington, KY 
 
2010   Teaching Assistant, KHP 450 Introduction to Exercise Testing and 
   Prescription 
   Department of Kinesiology and Health Promotion 
   University of Kentucky 
   Lexington, KY 
 
MANUSCRIPTS IN PROGRESS 
 
2012-Present  Macht, J., Abel, M., Mullineaux, D., and Yates, J.  Development of 
   1RM Prediction Equations for Bench Press in Moderately Trained  
   Male Subjects. 
 
SERVICE 
2014 – 2015    Tutor, Center for Academic and Tutorial Services 
    Subjects tutored:  KHP 415 – Biomechanics of Human  
    Movement 
    KHP 240 – Nutrition and Physical Fitness 
    KHP 450 – Introduction to Exercise Testing and   
    Prescription 
    KHP 573 – Management of Sport 
    University of Kentucky 
    Lexington, Kentucky 
 
68 
 
January 2014 – Present Time to Change Program 
    Exercise Progression Committee 
    Developed safe exercise progressions for overweight  
    population 
    Department of Campus Recreation 
    University of Kentucky 
    Lexington, KY   
MEMBERSHIPS 
Member, National Strength and Conditioning Association 
  
CERTIFICATIONS 
National Strength and Conditioning Association (NSCA) Certified Strength and 
Conditioning Specialist (CSCS) 
American Red Cross CPR/AED Adult Certification 
 
 
 
